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Abstract
Factor receptors from Saccharomyces cerevisiae are G-protein-coupled
receptors containing seven transmembrane segments. The abilty of a-factor receptors to
form oligomeric complexes with each other and with other proteins was investigated.
Both in vivo and in vitro evidence was obtained that suggests homo-oligomerization of
receptors in the plasma membrane. When the membranes from cells coexpressing two
differentially-tagged receptors were solubilzed with detergent and subjected to
immunoprecipitation, the antibodies specific for either epitope tag resulted in
precipitation of both tagged species. Treatment of cultures with a-factor had little effect
on the extent of oligomerization as judged by the sedimentation behavior of the receptor
complexes and by the efficiency of coimmunoprecipitation. The abilty of receptor
complexes to undergo ligand-mediated endocytosis was evaluated by using membrane
fractionation and fluorescence microscopy. Mutant receptors that fail to bind a-factor
(Ste2-S 184R) or lack the endocytosis signal (Ste2- T326) became competent for
ligand-mediated endocytosis when they were expressed in cells containing wild-type
receptors. Coimmunoprecipitation experiments indicated that the C-termnal cytoplasmic
domain and intermolecular disulfide bonds were unnecessar for oligomer formation.
Therefore, a-factor receptors form homo-oligomers and that these complexes are subject
to ligand-mediated endocytosis.
A crosslinkng and immunoprecipitation strategy was used to capture and
characterize the transient complexes that contain the a-factor receptor Ste2.. Tagged
receptors were crosslinked to form at least three high molecular weight complexes and
the complexes were immunoprecipitated with antibodies against the tag. Western
vii
blotting analysis of the precipitated material revealed the presence of 
and y subunits of
the heterotrimeric G protein , Ste4 and Ste18. Similar results were obtained when the
cultures had been treated with a-factor prior to analysis. A truncated receptor missing
most of the cytoplasmic C-terminal tail was also active in binding Ste4. Overall, these
results constitute the first biochemical evidence for a physical association between the
a..factor receptor and its cognate G-protein.
Endocytic signals in the C-terminal tail (residues 297-431) ofthe a-factor
receptor were analyzed. One signaling element, SINNDAKSS, (residues 331-339) is
known to be sufficient (but not necessary) for endocytosis. Internal deletions of the STE2
gene were constructed that remove sequences encoding SINDAKSS and selected
regions of the C-terminal tail. Strains containing these alelles were then assayed for
endocytosis in the presence and absence of a-factor. Residues from 360 to 431 were
sufficient to mediate both constitutive and ligand-mediated endocytosis of the receptor
even though 63 residues including the SINNDAKSS motif had been removed. Structural
features of this region that were investigated further were the highly-ubiquitinated
Lys374 , the neighboring Lys387 , and the GPFAD motif (residues 392-396). Lys374 and
Lys387 were unnecessar for the element to promote exit from the plasma membrane;
however, Lys374 may play some role in intracellular trafficking. The GPFAD motif was
not sufficient to promote endocytosis , since the residues 360-399 provided no detectable
endocytic activity. Overall , these results suggest that a new region in the C-termnal of
the a-factor receptor, redundant with the SINNDAKSS motif, is sufficient to mediate the
constitutive endocytosis as well as the ligand-mediated endocytosis of the receptor.
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CHAPTER I
INTRODUCTION
All cells need to sense changes in their environment and respond appropriately to
extracellular cues for survival. Complex signal transduction networks couple the outside
signals to cellular responses permtting them to alter the metabolic state, rate of growth
or morphology of the cell. The unicellular eukarote Saccharomyces cerevisiae has
proven to be a useful genetically tractable model organism to study signaling pathways as
well as other aspects of basic cellular functions. S. cerevisiae exists in either of two
forms in nature: haploid or diploid. Conjugation is initiated by the peptide pheromones
factor and a-factor that are secreted by the haploid a and a cells, respectively. The
faresylated and carboxymethylated undecapeptide a-factor binds to the a-factor receptor
the product of the STE3 gene, that is expressed on the surface of a cells. Similarly, the
factor receptor, the product of the STE2 gene, on a cells is the target of the
tridecapeptide a-factor. The binding of these pheromones to their specific receptors
initiates the prerequisite events for mating. The a and a cells arest early in G 1 thereby
synchronizing their respective cell cycles, and then undergo polarzed morphological
changes (e.g. they form cell-surface projections towards the opposite parner). 
addition, transcription of the mating-specific genes that are required to car out cell-cell
adhesion and fusion is activated.
In this chapter, I wil review briefly the current understanding of basic strctural
properties of the G-protein coupled receptor (GPCR) superfamily which includes the
mating pheromone receptors of S. cerevisiae. I wil also examine the data regarding
GPCR-G protein interactions; oligomerization of GPCRs and central features of plasma
membrane protein endocytosis in yeast as the data pertain to my findings presented in the
results chapters of this thesis.
protein-coupled receptors: structural and functional domains
The a-factor receptor (Ste2) and a-factor receptor (Ste3) are integral membrane
proteins with a topology that is characteristic of members of the GPCR family. GPCRs
comprise the largest and most diverse superfamily of cell-surface receptors (Bockaert and
Pin, 1999; Hebert and Bouvier, 1998). Examples include, ~-adrenergic, metabotropic
glutamate, Ca -sensing, dopamine, muscarnic , opioid, olfactory, taste, pheromone and
light-sensing receptors in mamals, frizzled/smoothened family in Caenorhabditis
elegans and cAMP activated receptors in Dictiosytelium. About 5% of the C. elegans
genome and perhaps 3% of the human genome encode for GPCRs (Bourne and Meng,
2000).
GPCRs possess a common seven-transmembrane domain topology with an
extracellular glycosylated N-termnal segment, a cytoplasmic C-termnal segment and
alternating intracellular and extracellular loops (Carwright and Tipper, 1991). The high
resolution crystal structure of rhodopsin, the light-sensing GPCR located in the rod cells
of the retina has unequivocally demonstrated the boundares, arangement and orientation
of the seven transmembrane a-helices and the intervening loops in this photoreceptor as
well as the contact sites for the covalently attached chromophore , retinal, in its ground
state (Pa1czewski K, 2000). The receptor transmembrane domains are tightly packed in a
bundle from helix one to seven in a clockwise direction when viewed from the
cytoplasm. The second intracellular loop and an eighth a helix formed by the C-termnus
lie parallel to the cytoplasmic face of the receptor creating a possible loading dock for
transducin, the heterotrmeric G protein in the retina which is the effector molecule for
rhodopsin. Overall the results are mostly in agreement with previous data obtained by
cryo-electron microscopy, mutational analyses and other biochemical studies of
rhodopsin (Bourne and Meng, 2000; Palczewski K, 2000). Most other members of the
GPCR superfamily are predicted to have transmembrane helices and extracellular loops
of comparable size to rhodopsin. Therefore, a similar transmembrane topology has been
proposed for other GPCRs.
Despite their overall similarty in strcture, GPCRs show little sequence
conservation and respond to a varety of extracellular stimuli such as light, odorants,
calcium, hormones and neurotransmitters. The smallest ligands (retinal, amines,
nucleosides and lipid moieties) bind to a hydrophobic pocket formed by the core
transmembrane helices, whereas small peptides bind both to the core and to extracellular
loops. Higher molecular weight peptides and protein ligands usually bind to the
termnus and the extracellular loops, whereas glycopeptides bind solely to the
termnus (Ji et aI., 1998). Most ligands bind the receptors reversibly whereas in the
case of rhodopsin and thrombin receptors, the ligands are covalently associated with the
receptor. Retinal is bound to Lys296 of rhodopsin by a protonated Schiff base linkage
and stabilized by a salt bridge with Aspl13 (Palczewski K, 2000). The N-termnal
segment of thrombin family of receptors is cleaved by proteases, and the cleaved peptide
acts as a ligand to activate the receptor.
One important aspect in GPCR activation is assembly of the right combination of
receptor with the appropriate G protein subset from the cytoplasmic pool. Commonly,
the intracellular loop 3 of a GPCR determnes the Ga~y selectivity (Bourne, 1997). In
some instances intracellular loop 2 and rarely intracellular loop 1 have been implicated in
establishing the specificity of the interaction with G proteins (Bourne , 1997). So far, it is
not possible to predict the G protein trimer that wil interact with a given GPCR based
solely on its primar structure (Bourne, 1997). In some instances , the carboxy termnal
tail of the receptor is also involved in binding to the G proteins. The C-termnal tail of
Ste2 has been proposed to function in stabilizing the receptor-G protein interactions
(Dosil et aI. , 2000), whereas the intracellular loop 3 has been proposed to bind the G
proteins. The carboxy termnal tail is also implicated in adaptation, endocytosis and
oligomerization (Cvejic and Devi , 1997; Rohrer et aI., 1993; Schandel and Jenness,
1994).
Two conserved cysteines are present in many GPCRs, one in extracellular loop 
at the transmembrane helix 3 boundar and one in extracellular loop 2. The
corresponding cysteines Cys 187 and Cys 11 0 in bovine rhodopsin form an intramolecular
disulfide bond, covalently' attaching these regions and perhaps stabilzing correct folding
(Palczewski K, 2000). Cysteines present in some GPCRs , such as Ca -sensing and
metabotropic glutamate receptors, are required for oligomerization (Bai et aI., 1998;
Romano et aI., 1996). The two cysteine residues in Ste2 do not seem to be required for
receptor function since a receptor mutant that contains neither of these cysteines exhibits
no defects in plasma membrane localization, signaling, endocytosis or oligomerization
(Jeremy Thorner personal communication, (Yesilaltay and Jenness , 2000)).
G protein structure and functional domains
GPCRs rely on the action of heterotrimeric G proteins to relay the extracellular
signals to the cell interior. Receptor stimulation by the ligand results in exchange of GDP
for GTP in the a subunit of the G protein, and it is thought that the GTP-bound Ga
dissociates from the G~y heterodimer. In mammalian cells, the GTP-bound Ga regulates
downstream effectors such as adenylyl cyclases, phospholipases and ion channels (Meigs
et aI. , 2001). In some cases , G~y subunits have been shown to interact with protein
serine/threonine kinase KSR- l and PI3Ky. (Naor et aI. , 2000). Yeast cells elicit a
response through the yeast homologs of the mammalian a, ~ and y subunits of the
heterotrmeric G protein (encoded by GPAi , STE4 and STEi8 genes , respectively) that
are coupled to the a- and a-factor pheromone receptors (Ste2 and Ste3, respectively)
(Dohlman and Thorner, 2001). In yeast, it is the G~y heterodimer that activates the
downstream effectors. Ga has a slow intrnsic GTPase activity. In addition, the GTPase
activity of Ga is regulated by RGS proteins (regulator of GPCR signaling). Phosducins
on the other hand , modulate the function of G~y. When GTP is hydrolyzed , the
GDP-bound Ga is likely to reassociate with the G~y heterodimer.
The high resolution crystal structure of the G protein has revealed the contact sites
among subunits. The G~ is shaped like a propeller with seven blades and a shaft domain
(Lambright et aI., 1996; Sondek et aI. , 1996; Wall et aI. , 1995). Ga and G~ interact at
two major sites, at the lipid-modified amino terminus and at the switch region of Ga. 
is the association of the switch region of Ga with an electronegative region on G~ that is
thought to regulate the activity of the switch region. However, it is stil unclear where the
receptor and the downstream effectors interact with the G protein.
Ste2-G protein interactions
A number of models have been proposed to explain the GPCR activation.
According to the ternary complex model, GPCRs are thought to exist in an equilibrium
between an inactive (R) state and an active (R*) state. In the absence ofthe ligand, most
receptors are in the R state. Ligand binding stabilzes the R * state. The potency of a
ligand is defined as a function of its ability to alter the equilibrium in favor of the active
state. The ligand-bound receptor interacts transiently with the G protein causing a
GDP-GTP exchange on the Ga subunit. A modified version of the ternar complex
model (Samama et aI. , 1993) accounts for the existence ofreceptor-G protein complexes.
In the modified model , receptors isomerize and assume many intermediate states
(including the R * state) even in the absence of the ligand. Thus, a fraction of receptors
(those in R * state) can associate with the G protein in the absence of the ligand. These
precoupled receptor-G protein complexes are referred to as 'pre-activation complexes
These complexes may playa role in enhancing the specificity and the efficiency of the
receptor-G protein interactions.
In yeast, varous indirect observations indicate a physical interaction between the
receptor and its cognate G protein. For example the affinity of the receptor for the ligand
is decreased in a ste4/J strain (Jenness et aI., 1987). Similarly, truncated receptors , which
are thought to lack the ability to stabilze G-protein interactions , also have lower affinity
for the ligand than full-length receptors (Dosil et aI. , 2000). In addition, a-factor
dissociates from receptors more rapidly when GTP analogs are present or when
membranes are assayed from mutant cells that lack G protein subunits (Blumer and
Thorner, 1990). Finally, the dominant negative phenotype associated with receptor
mutants is reversed when the G proteins are overexpressed (Dosil et aI. , 1998). Genetic
analyses also indicate that the third cytoplasmic loop of Ste2 is the site for the G protein
interactions since mutations in this region either render the receptor constitutively active
or abolish signaling. Consistent with this idea, the lethality phenotype associated with a
temperature-sensitive allele of Ga (gpai-A345T) resulting from constitutive activation of
G~y, is rescued by a double mutation affecting the third cytoplasmic loop region of Ste2
(ste2- Y266C-L236H) (Dosil et aI., 2000). Allele-specific interactions of this kind suggest
a specific physical association. However, direct biochemical evidence for physical
association of the receptor and G protein has not been described in this system.
Genetic evidence suggests the existence of pre-activation complexes in yeast, and
the C-termnal tail of Ste2 is thought to stabilze the interaction between the receptor and
the G protein (Dosil et aI., 2000). First, ligand-binding-defective dominant negative
mutants of Ste2 that interfere with signaling from the wild-type receptors failed to do so
if they lacked the C-termnal cytoplasmic tail. Second, the C-termnal tail was also
required for wild-type receptors to interfere with the signaling from a constitutively
active receptor in the absence of the ligand. Finally, GPAi-A345T allele causes lethality
at restrictive temperature in a ste2/J strain or in a strain expressing a C-termnally
truncated Ste2 mutant, however cells expressing Gpal-A345T were viable when full-
length receptors were expressed. These data indicate precoupling of the receptor and G
protein in the absence of the ligand, and that the C-termnal tail of the receptor has a role
in stabilizing the receptor-G protein interactions.
One reason why the receptor-G protein complexes have not been reported so far
could be that these proteins are held together by weak interactions which dissociate
during the immunoprecipitation procedure. In Chapter IV of this thesis, I present a
crosslinking and immunoprecipitation approach to capture these putative complexes. I
found that Ste4 crosslinks to and coimmunoprecipitates with Ste2 both in the absence and
in the presence of the ligand suggesting a direct interaction between these two proteins
and lending direct support to the existence of the pre-activation complexes in yeast.
Furthermore, I was able to capture ligand-independent complexes between G~ and
trncated receptors , indicating that complexes can form, at least transiently, without the
stabilizing influence of the C-termnal tail.
GPCR oligomerization
Early observations. While the current models of GPCR activation do not address
the oligomeric state of the receptor, they do not theoretically exclude the possibilty 
receptor oligomers. In fact, receptor oligomerization may play an unforeseen role in
function. Early biochemical and genetic findings suggest oligomerization of Ste2 and
other GPCRs. At subsaturating concentrations of a-factor, Jenness and Spatrick
observed that the rate of labeled a-factor endocytosed by the yeast cells was slower than
the rate of a-factor receptor site loss from the plasma membrane (Jenness and Spatrick,
1986). One interpretation of this result is that unoccupied receptors internalize with the
occupied ones in aggregates. Receptor aggregates were detected in SDS-P AGE analysis
of both GPCRs (~ adrenergic receptor, dopamine D2 receptor, muscarinic receptor, Ste2)
(Avissar et aI. , 1983; Blumer et aI. , 1988; Conn and Venter, 1985; Hebert et aI., 1996)
and other membrane proteins (glycophorin A, human erythrocyte band 3) (Furthmayr and
Marchesi , 1976; Salhany et aI. , 1990) and named ' SDS-resistant' dimers. It is currently
unclear whether these species represent physiologically relevant receptor dimers or
non-specific aggregates that form during sample preparation.
Early genetic data also suggested oligomerization. Konopka and Jenness detected
allele-specific complementation of mating-defective a-factor pheromone receptor
mutants (Konopka and Jenness, 1991). Three signaling- defective STE2 alleles that
contained linker insertion mutations in or near transmembrane segments 1 , 2 and 6
parially rescued the temperature-sensitive mating defect of the ste2- allele upon
coexpression, whereas two other alleles with mutations at transmembrane segments 4 and
6 failed to do so (Konopka and Jenness, 1991). Similarly, two receptor chimeras formed
between a2 adrenergic and m3 muscarnic receptors which contained the first five
transmembrane domains from one receptor and the last two transmembrane domains
from the other receptor failed to bind the ligand for either receptor or to signal , unless the
two chimeras were coexpressed, leading the investigators to argue that the two receptor
chimeras oligomerized to form functional receptors (Maggio et aI., 1993). More recently,
a ligand-binding-defective phenotype of angiotensin receptor was complemented by
coexpressing a second receptor containing a different defect in ligand binding (Monnot et
aI. , 1996). Other allele-specific effects were observed with both V2 vasopressin and
CCR5 receptors. Dominant-negative mutant receptors inhibited signaling from wild-type
receptors when they were coexpressed, presumably by oligomerizing with the wild-type
receptors and thereby causing the wild-type receptors to be retained in the intracellular
compartments with the defective receptors (Benkirane et aI. , 1997; Zhu and Wess, 1998).
Detecting GPCR oligomers. Recent reports indicate that oligomerization may be
a universal phenomenon for GPCRs. Evidence suggesting oligomerization was obtained
through crosslinkng and coimmunoprecipitation approaches. Examples include ~2
adrenergic (Hebert et aI., 1996), 8-opioid (Cvejic and Devi, 1997), D2 and D3 dopamine
(Ng et aI. , 1996; Nimchinsky et aI. , 1997), m3 muscarinic (Zeng and Wess , 1999),
metabotropic glutamate (Romano et aI. , 1996) and Ca -sensing (Bai et aI. , 1998; Bai et
aI., 1999), V2 vasopressin (Hebert et aI. , 1996), bradykinin B2 (AbdAlla et aI. , 1999),
and somatostatin receptors (Rochevile et aI. , 2000). In addition, varous resonance
energy transfer methods revealed homo-oligomers of ~2 adrenergic, 8-opioid and SSTR5
somatostatin receptors in living cells (Angers et al. , 2000; Kroeger et aI. , 2001; McVey et
aI., 2001). Furthermore, the high resolution crystal structure of the ligand binding
domain of glutamate receptors demonstrated that the domain was a dimer both in
ligand-bound and unbound states (Kunishima et aI. , 2000).
Hetero-oligomerization of varous GPCRs was also reported. GPCR heterodimers
were detected with receptors of the same subtype for K- and 8 opioid receptors; - and 8
opioid receptors; somatostatin receptors SSTRI and SSTR5; and GABA Rl and R2
receptors (George et aI., 2000; Jordan and Devi, 1999; Kuner et aI. , 1999; Rochevile et
aI. , 2000). Recent reports indicate that hetero-oligomer formation does not require
subtype specificity since D2 dopamine receptors oligomerize with SST5 somatostatin
receptors (Rochevile et aI. , 2000). Type 1 angiotensin II receptors and B2 bradykinin
receptors were found to form hetero-oligomers as well (AbdAlla et aI. , 2001).
The effect of ligands on oligomerization. Although receptor oligomerization is
emerging as a common theme, the influence of agonists on receptor oligomerization has
been shown to vary among the GPCRs investigated. For example, agonists appeared to
stabilize dimers of ~2 adrenergic receptors prepared from COS-7 cell membrane extracts
in a dose-dependent manner when the amount of SDS-resistant dimer formation was used
as a criterion (Hebert et aI., 1996). Similarly, a slight agonist-induced increase in
oligomerization was reported in bioluminescence resonance energy transfer (BRET)
experiments when fusion receptor constructs (~2 adrenergic receptor-luciferase and
adrenergic receptor-green fluorescent protein) were used (Angers et aI. , 2000). The
oligomeric state of m3 muscarnic receptors is not altered when COS-7 cells expressing
m3 receptors are treated with the muscarnic receptor agonist carbachol (Zeng and Wess
1999). On the other hand, the monomeric state of 8-opioid receptor is apparently favored
upon agonist binding (Cvejic and Devi, 1997). In this study, stably transfected Chinese
hamster ovar cells were treated with a number of opioid agonists , and the oligomeric
state was evaluated by comparng the monomer versus dimer ratio on SDS-P AGE-
analysis. However, McVey et ai. detected no change in 8-opioid receptor
oligomerization using two separate resonance energy transfer techniques (McVey et aI.
2001). It should be noted that findings from resonance energy transfer techniques should
be approached with caution, because the lack or ability to detect an interaction does not
depend merely on the distance between two molecules but also on the relative alignment
of the fluorophores. For example, even though no interaction is detected between two
receptor constructs , agonist binding may induce a conformational change in the
already-existing receptor homo-dimer thus generating improved energy transfer. Overall
whether these results reflect different experimental conditions or whether they represent
bona-fide ligand-mediated effects on GPCR oligomerization remains to be determned.
Mechanisms of oligomer formation. The strctural determnants of the receptor
that are important for oligomerization have also proven to be diverse. 15 amino acids in
the C-termnal tail of 8-opioid receptor have been implicated in dimerization, since
deleting these 15 amino acids prevents both receptor internalization and receptor
oligomerization (Hebert et aI. , 1996). Interestingly, the GABA Rl and R2 receptors
(also referred to as GBRI and GBR2) oligomerize through coiled-coil domains at their
termni (White et aI. , 1998). However, the C-termnal tail of the 8-opioid receptor has
no obvious coiled-coil domain (Miligan, 2001). A mutant bradykinin B2 receptor that is
truncated at the N-termnus fails to oligomerize, underscoring the importance of this
domain for oligomerization (AbdAlla et aI. , 1999). The Ca -sensing receptor, the
metabotropic glutamate receptor 5 and the muscarinic m3 receptor oligomerize though
intermolecular disulfide bonds (Bai et aI. , 1998; Romano et aI. , 1996; Zeng and Wess,
1999). Transmembrane region VI is thought to mediate the association of ~2 adrenergic
receptors since peptides containing this sequence interfere with the recovery of receptor
dimers (Hebert et aI. , 1996). On the other hand, peptides derived from varous
transmembrane domains of the dopamine D2 receptor inhibit receptor oligomerization
(Ng et aI., 1996).
Two models have been proposed to explain how the GPCRs form oligomers
(Gouldson et aI. , 2000). Both models predict that the interaction between receptors
involve multiple contacts between transmembrane helices V and VI. According to
domain swapping model , GPCRs are comprised of two independently folding segments,
the transmembrane helices I-V and VI-VII. These two domains can be split and
coexpressed to form functional receptors (Barbier et aI. , 1998; Scarsell et aI. , 2000).
This model suggests that the GPCR dimers form by exchanging the two independent
folding domains, that is the first five transmembrane helices are contributed from one
receptors and the last two from the other. The contact dimer model proposes that the
dimer formation is simply mediated by lateral interactions between transmembrane
helices. Further experiments are ne ded to distinguish these two models.
Role for GPCR oligomerization in signal transduction. The functional
significance of GPCR oligomerization is currently unclear. Agonist stimulation has led
to increased oligomerization of ~2 adrenergic and CCR5 receptors (Angers et aI. , 2000;
Hebert et aI. , 1996; Vila-Coro et aI. , 2000). Hebert et al. suggest that the oligomerization
of ~2 adrenergic receptors regulates the signaling from these receptors since the peptide
derived from the transmembrane region VI of ~2 adrenergic receptor inhibited both
oligomerization and adenylyl cyclase activity of the receptor, whereas another peptide
derived from transmembrane region VII of the dopamine receptor failed to interfere with
either process (Hebert et aI., 1996). This suggestive evidence is contrasted by the work
of George and coworkers who showed that a peptide derived from transmembrane VI of
dopamine receptor Dl also inhibited the adenylyl cyclase activity without disrupting Dl
receptor oligomers (George et aI. , 1998). In addition, when anti-~2 adrenergic receptor
antibodies were allowed to interact with the receptors , bivalent antibodies but not
monovalent Fab fragment antibodies, caused receptor activation (Mijares et aI. , 2000),
consistent with a role for oligomerization in signal transduction. It is intriguing to note
that cooperative interactions of G proteins have been reported (Wessling-Resnick and
Johnson, 1989). Crystallographic data demonstrated Gail in oligomeric arays (Chidiac
and Wells, 1992; Mixon et aI., 1995). This has prompted investigators to argue that
GPCRs and G proteins may be organized in arays in the plasma membrane facilitating
signaling from these receptors (Rodbell, 1992).
Oligomers in chaperoning and transport. A potentially interesting insight into the
role of oligomerization comes from the studies with GABA receptors. The first GABA
receptor to be cloned was GABA Rl (Kaupmann et aI. , 1997). However, this receptor
bound agonist ligands poorly when expressed in recombinant systems , and when it was
expressed in mammalian cells, it was retained in intracellular comparments as an
immature glycoprotein. A closely related seven transmembrane protein, named GBR2
was simultaneously identified by a number of groups (Jones et aI. , 1998; Kaupmann et
aI., 1998; Kuner et aI. , 1999; White et aI. , 1998). Expression of GBR2 inhibited adenylyl
cyclase activity but only coexpression with GBRI activated the outward potassium
channels (Kuner et al. , 1999). Therefore, the full physiological activity of GABA has
been suggested to require the hetero-oligomerization of the two receptors. Coexpression
of GBR2 with GBRI rescued the intracellular retention defect of GBRI. Therefore, a
role for oligomerization in proper folding and chaperoning of the receptors has also been
proposed. Subsequently, an ER-retention signal was identified in GBRl , and the authors
argue that the coiled-coil interactions in the C-termnal tails of GBRI and GBR2 mask
the ER-retention signal in GBRl , thereby regulating the ER export and plasma membrane
trafficking of this receptor.
The ability of oligomers to form in the ER is also supported by studies with
mutant vasopressin receptors. A vast majority of the clinically relevant mutations
affecting the vasopressin receptors cause nephrogenic diabetes because the mutant
receptors are retained in the ER. Dimers of these mutant receptors have been detected.
These results suggest that oligomers form in the ER and that receptors are transported as
oligomers to the plasma membrane. In addition, it has been proposed that a trncated
form of CCR5 causes wild-type receptors to be retained in the ER. Since CCR5 is a co-
receptor for HIV entry, the slow onset of AIDS in patients caring a single copy of this
allele may be a consequence of the absence of the wild-type copy of the receptor on the
plasma membrane.
Potential role for receptor hetero-oligomerization in altering the binding affnity
and specifcity of ligands. An extra level of regulation in receptor response may be
achieved by altering functional properties of receptors through hetero-oligomerization.
The 8- and K -opioid receptors , as well as &- and ~-opioid receptors, have been shown to
form hetero-oligomers (George et aI., 2000; Jordan and Devi , 1999). Cells coexpressing
8- and K-opioid receptors exhibit binding specificities and affinities distinct from cells
expressing the individual receptors (Jordan and Devi , 1999). Similar novel properties
have been reported with regard to the coexpression of 8- and ~-opioid receptors (George
et aI. , 2000). One caveat of both studies is that the experiments were performed with
transfected cells that overproduced receptors. Interpreting the physiological relevance of
these results wil require knowledge of the relative levels of the receptor subtypes in
normal cells. These findings may also have clinical importance since the heterodimer 
homodimer ratio may affect the pharacological properties of the response.
Oligomerization and endocytosis. A role for oligomerization in endocytosis has
also been proposed. The monomerization of 8-opioid receptors by the agonist DAMGO
precedes their endocytosis (Cvejic and Devi , 1997). Another opioid agonist morphine
that does not induce endocytosis of these receptors also does not promote
monomerization. In addition , when the C-termnal15 amino acids responsible for
oligomerization are deleted, the receptors fail to undergo ligand-mediated endocytosis.
Therefore the authors suggest that the monomeric species is actively endocytosed and
that monomerization is required for internalization (Cvejic and Devi , 1997).
Chapter III of this thesis presents evidence indicating that Ste2 forms oligomers.
Ste2 oligomers were also detected by fluorescence resonance energy transfer experiments
(Overton and Blumer, 2000). The findings indicate that the formation of oligomers is
unaffected by ligand and that receptors are endocytosed in oligomeric complexes
suggesting that oligomerization potentially faciltates endocytosis rather than mediating
signaling by Ste2.
Endocytosis of GPCRs
Upon agonist stimulation, GPCRs are phosphorylated at serine and threonine
residues by G-protein-coupled receptor kinases (GRKs) (Krpnick and Benovic 1998). A
special class of proteins called arestins is involved in both desensitization and down
regulation of receptors (Krpnick and Benovic 1998). Binding of arestins to
phosphorylated GPCRs prevents receptors from reassociating with G proteins.
Furthermore, arestins induce clathrn-mediated endocytosis of receptors by recruiting
components of adaptor protein complex (AP-2). ~-arestins have been shown to bind
clathrn and ~2-adaptin of AP-2 complex (Krpnick et ai. 1997; Laporte et al. 1999). A
large GTPase , dynamin, is required for pinching off the endocytic vesicle containing
receptors from the cell surface (McNiven, 1998). Following internalization, receptors are
either recycled back to the surface or are transported to the lysosome for degradation.
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Endocytosis of Ste2
The C-termnal cytoplasmic tail of Ste2 mediates its constitutive and
ligand-mediated endocytosis (Fig. 1). Truncated receptors lacking 105 amino acids out
of 134 tail residues cause 4-5 fold increased pheromone sensitivity, defects in recovery
from pheromone and desensitization and defects in both constitutive and ligand-mediated
endocytosis of the receptor (Konopka and Jenness , 1991). Nested deletions of the STE2
gene have been constructed that result in consecutive truncations of the receptor staring
from its C-termnus. Analysis of these mutants indicates that the first 39 amino acids
immediately following the transmembrane region VII contain sufficient information to
promote both constitutive and ligand-mediated endocytosis of the receptor, albeit at a
reduced rate than the wild-type receptor (Rohrer et aI. , 1993). Further mutational
analysis of the truncated receptor containing this 39 amno acid element, Ste2- T345,
identified a nine amino acid motif SINNAKSS required for residual endocytic activity
of Ste2-T345. In addition, the SINNDAKSS sequence (even the DAKSS sequence) is
sufficient to confer endocytosis of a severely truncated receptor (Rohrer et aI. , 1993).
The substitution of Lys337 by either alanine or arginine abrogates the abilty of this motif
to promote endocytosis of the severely truncated receptor, and it blocks the abilty of
cells expressing this construct to recover from a-factor exposure. Further analysis of the
truncation mutant indicated that Lys337 is ubiquitinated (Hicke and Riezman, 1996).
Ubiquitination of plasma membrane proteins. Ubiquitin, a well-conserved 76
amino acid protein, was originally identified as a tag that directs proteins to the
proteasome for degradation (Hochstrasser, 1996). Ubiquitin forms an isopeptide bond
through its C-termnal glycine and a lysine residue on a protein. The sequential action of
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Figure 1. The predicted topology of the a-factor receptor. The endocytosis motif
SINNDAKSS sequence is denoted in gray. The residue 345 is marked with an arow.
three enzymes is required for the ultimate transfer of ubiquitin to the target protein: the
ubiquitin activating enzyme (E1), ubiquitin conjugating enzyme (E2 ) and ubiquitin
protein ligase (E3 ) (Hochstrasser, 1996). Cytoplasmic and nuclear proteins are marked
for degradation with multiple ubiquitin chains. Each link in the chain is formed by the
modification of the lysine residue at position 48 on one ubiquitin molecule with a second
ubiquitin molecule. Following ubiquitination , proteins are targeted to the 26S
proteasome. Ubiquitin also serves as an endocytic signal for several membrane proteins
in yeast. Some examples include the pheromone receptors Ste2 and Ste3 (Hicke and
Riezman, 1996; Roth and Davis , 1996), transporters Ste6 and Pdr5 (Egner and Kuchler
1996; Kollng and Hollenberg, 1994) and permeases Fur4 , Gap1 , Gal2 and Mal61 (Galan
et aI., 1996; Horak and Wolf, 1997; Medintz et aI. , 1998; Springael and Andre, 1998).
Ubiquitin was also shown to be important for the endocytosis of the growth hormone
receptor in mammalian cells (Govers et aI. , 1997; Hicke, 1997; Strous et aI. , 1996).
Yeast contains ubiquitin chains that are linked through isopeptide bonds at Lys29,
Lys48 or Lys63 (Amason and Ellson, 1994; Hicke, 2001). It has been suggested that the
position of the linkage determnes the fate of the ubiquitinated proteins. Tetraubiquitin
chains linked through Lys48 mark proteins as substrates for the proteasome, whereas
diubiquitin chains linked through Lys63 have been implicated in endocytosis of Fur4 in
yeast. So far, the proteins caring ubiquitin chains linked through Lys29 have not been
identified (Hicke, 2001).
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Ubiquitination of Ste2. Ubiquitination is thought to be necessar for endocytosis
of Ste2 in yeast (Hicke and Riezman, 1996). First, an end4 strain which causes an overall
defect in endocytosis of many cellular plasma membrane proteins as well as Ste2
! J
accumulates high molecular weight species of Ste2 which have been identified as
ubiquitinated forms of the receptor using a sequential immunoprecipitation procedure
when Ste2 antibody was followed with anti-ubiquitin antibody. In addition cells lacking
ubiquitin conjugating enzymes ubcl ubc4 and ubc4 ubc5 also have defects in
endocytosis. Furthermore , Ste2 turnover is apparently not mediated by the cytoplasmic
proteasome but requires the action of vacuolar proteases. Deletion of two vacuolar
proteases, Pep4 and Prb1 , that cleave and result in the activation of other vacuolar
hydrolases led to a marked increase in receptor half life and accumulation of
ubiquitinated forms of the receptor. On the other hand, the half-life of Ste2 was
unaffected in pre1pre2 double mutant cells that lack two essential ~ type subunits of the
proteasome (Hicke and Riezman, 1996).
Terrell and coworkers demonstrated that Ste2 is monoubiquitinated on multiple
lysine residues and that monoubiquitination is sufficient to drive the endocytosis of the
receptor (Terrell et aI. , 1998). To this end, the authors constrcted a double mutation 
the ubiquitin molecule, Ub-K48R/G76A. The lysine to arginine change at position 48 is
commonly used to block poly-ubiquitin chain formation in the substrates of the
proteasome. The alanine to glycine change at the C-termnus inhibits the removal of
ubiquitin once it has been attached to the substrate. This mutant Ub-K48R/G76A has
been previously shown to inhibit degradation of ubiquitinated substrates by the
proteasome. Ste2 endocytosis is unaffected by the presence of this ubiquitin mutant.
Moreover, other ubiquitin mutants that harbor different lysine to arginine substitutions
alsoJail to affect the endocytosis of Ste2. Similar results were obtained when a ubiquitin
. mutant that harbors lysine to alanine substitutions of all of the lysines, Ub-NoLys, was
expressed in a strain which lacks the deubiquitylation enzyme Doa4. The presence of
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mono- and di-ubiquitinated forms of Ste2 as judged by SDS-PAGE analysis in the
Ub-NoLys-expressing strain indicates monoubiquitination of Ste2 at one or two lysine
residues rather than poly-ubiquitination (Terrell et aI. , 1998).
Phosphorylation of Ste2. Ste2 is phosphorylated at serine and threonine residues
in its C-termnal tail. Upon binding a-factor, Ste2 becomes hyperphosphorylated
(Reneke et al. , 1988). Hyperphosphorylation causes Ste2 to migrate more slowly on SDS
gels. Substituting serine residues for alanines in the SINNDAKSS motif of Ste2- T345
inhibited both endocytosis and the a-factor-induced mobility shift of the mutant receptor
(Hicke et aI. , 1998). In addition, yeast cells caring mutations affecting yeast casein
kinase I homologues fail to internalize a-factor and do not phosphorylate or ubiquitinate
their receptors (Hicke et aI. , 1998). Therefore, it has been proposed that phosphorylation
may be a prerequisite for ubiquitination. Since ubiquitination mediates receptor
endocytosis, phosphorylation may be required for endocytosis of Ste2. Currently, it is
not clear whether the yeast casein kinases directly phosphorylate the tailor whether they
regulate other kinases. Unlike a-factor receptors, the internalization of a-factor receptors
is independent of pheromone response pathway since mutants defective for Ga subunit
Gpa1 , G~ subunit Ste4 or the scaffolding protein Ste5 remain subject to a-factor-induced
endocytosis (Blinder and Jenness , 1989; Jenness and Spatrck, 1986; Schandel and
Jenness , 1994; Zanolari et aI. , 1992). Similarly, a receptor mutant that is defective in
signaling is proficient in ligand-mediated receptor endocytosis (Schandel and Jenness,
1994). Therefore, the kinases responsible for Ste2 phosphorylation are unlikely to be the
protein)kinases regulated by the pheromone response pathway.
In Chapter V of this thesis, I report the identification of a new region of the
terminal tail of Ste2 that is sufficient to mediate both the constitutive and
ligand-mediated endocytosis of the a-factor receptor. I describe the endocytic properties
of a mutant form of Ste2 that lacks the well-characterized SINNDAKSS endocytic motif.
Specific mutants that remove other regions of the C- terminal tail in addition to
SINNDAKSS were used to delineate the position of the second endocytic element.
CHAPTER II
MATERIALS AND METHODS
Plasmids. pJBK008 is a yeast centromeric plasmid that contains the STE2 and URA3
genes (Konopka et aI. , 1988). pYe(CEN3)30 is a yeast centromeric plasmid that contains
the TRP i gene (Fitzgerald-Hayes et aI. , 1982). Plasmid pNED1(-Cys) (provided by Pam
Torrance and Jeremy Thorner) is a derivative of plasmid pNEDl (David et aI. , 1997); it
encodes a modified Ste2 that contains both the FLAG epitope and the 6His tag at the
termnus , lacks Cys residues 59 and 252 , and is expressed from the TDH3 promoter.
pDJ123 (provided by Kim Schandel) was constructed by cloning the 4. 3 kb BamHI
fragment that contains the STE2 gene into the BamHI site of plasmid vector
pYe(CEN3)30. pDJ323 (provided by Gul Bukusoglu) contains Ste2-Si84R and was
created by hydroxylamne mutagenesis of plasmid pJBK008; the STE2 coding region was
confirmed by DNA sequencing. Plasmid pEL36 cares the flankng STE4 sequences
whereas the complete coding sequence has been replaced with URA3 (Leberer et aI.
1992). Cutting pEL36 with EcoRI and transformng yeast results in the chromosomal
deletion of the STE4 gene. Plasmid pDA6300 is a yeast episomal plasmid that contains
the MFai and LEU2 genes. The yeast integrating plasmid pDJ338 contains the URA3
gene, and it directs synthesis of a fusion protein that contains the a-factor receptor and
the green fluorescent protein mutant GFP-S65TN163A, (from here on referred to as
GFP) tInder the control of the STE2 promoter (Li et aI. , 1999). Integrating plasmid
pDJ379 contains the URA3 gene and the STE2 co dons 302 to 431 fused to the coding
sequence for GFP (Li et aI. , 1999). Cleavage of pDJ379 with PstI followed by
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integration at the chromosomal STE210cus results in production of full-length Ste2p
tagged at the C-terminus with GFP. Integrating plasmid pDJ466 contains the TRP i gene
and STE2 codons 302 to 431 fused to the coding sequence for the triple influenza
hemagglutinin (HA) epitope. Cleavage of pDJ466 with PstI followed by integration at
the chromosomal STE2 locus results in production of full-length Ste2p tagged at the
termnus with the triple HA epitope. pDJ466 was constructed in two steps: first, the
0.4 kb NsiI/SacII fragment from pDJ338 (containing STE2 co dons 302 to 431) was
subcloned into plasmid vector pRS304 (Sikorski and Hieter, 1989) that had been cut with
PstI and SadI; and second, the resulting plasmid was digested with Sad and SadI and
ligated with the SacI/SacII-digested product of a PCR reaction that contains the triple HA
epitope DNA (from Mike Tyers) as template and oligonucleotide primers PO- 140
(CGTGCCGAGCTCCCATGGTCAAGCAGCGT AATCTGGAACGTCA TA) and
PO- 177 (GGCTCCCCGCGGTCTTTT ACCCA T ACGA TGTTCCTGACT AT).
Integrating plasmid pDJ467 contains the URA3 gene and STE2 codons 156 to 326 fused
to the GFP-coding sequence. Cleavage of pDJ467 with ClaI followed by integration at
the chromosomal STE2 locus results in production of Ste2- T326 tagged at the C-termnus
with GFP. pDJ467 was constructed by ligating the 4. 5 kb NsiI/SacII fragment (lacking
STE2) from pDJ320 with the PstI/SacII-digested product of a PCR reaction that
contained STE2 DNA (pDJ320) as template and oligonucleotide primers PO- 141
(GCGAAACTGCAGGGCGACAACTTCAAAAGGA TAGGTTT) and PO- 147
(CCACACCTACGAGTTCAA). pDJ469 (provided by Padhma Radhakshnan) is a
yeast centromere plasmid that contains URA3 and directs synthesis of Ste2- T326 tagged
at the'C- termnus with GFP. pDJ469 was created by cloning the ClaI-XbaI fragment
(containing STE2 codons 259 to 326 and GFP) from pDJ467 into ClaI-SpeI sites in
plasmid pDB02 (Dube and Konopka, 1998). Integrating plasmid pDJ470 contains TRP i
and STE2 codons 156 to 326 fused to the triple HA-coding sequence. Cleavage of
pDJ470 with Ec047III followed by integration at the chromosomal STE210cus results in
production of Ste2-T326 tagged at the C-termnus with the trple HA epitope. pDJ470
was created in two steps. In the first step, primers PO- 177 and PO- 186
(GCGAAAGGT ACCGGCGACAACTTCAAAAGGA T AGGTTT) were used to amplify
DNA encoding the trple HA epitope, and the PCR product was cloned between the SacII
and XbaI sites of plasmid pDJ467 replacing the GFP gene. In the second step, a 0.6 kb
sequence in this plasmid (containing STE2 codons 156 to 326 and the triple HA epitope)
was PCR -amplified with oligonucleotide primers PO- 140 and PO- 141 , and the
PstI/SacI-digested product was cloned between the PstI and SacI sites of pRS304.
Integrating plasmid pA Y61 contains the URA3 gene , and it directs synthesis of a fusion
protein that contains the a-factor receptor lacking codons 297 to 360 and the green
fluorescent protein (GFP) under the control of the STE2 promoter. It was created in two
steps. First, the ClaI/SacII digest of the PCR product obtained from template
pJBK063- 12 with primers PO- 141 and PO-
(GCGGCCCGCGGCT AAA TT A TT A TT A TCTTCAGTCCAGAA) was cloned into the
3 kb ClaI/SacII fragment of pDJ338. Then a mutation was corrected by cloning the
ClaI/SacII fragment of PCR product obtained the template from the previous step with
primers PO-273 (GGTTCCA TCGA T AA T A TTCA TCCTCGCA T ACAGTTTGAAACC)
and PO-88 (GCGCGGCCGTCT AGA TT A TTTGT AT AGTTCA TCCA TGCCA T) into the
5 kb ClaI/SacII site into the plasmid from the previous step. Integrating plasmid pA Y62
contains the URA3 gene , and it directs synthesis of a fusion protein that contains the
factor receptor lacking codons 297 to 391 and the green fluorescent protein (GFP)
under the control of the STE2 promoter. Plasmid pA Y62 was created by cloning the
ClaI/SacII fragment of PCR product obtained from the template pJBK063- 16 with
primers PO- 141 and PO-92 into the 5 kb ClaI/SacII fragment of pDJ338. Integrating
plasmid pA Y66 contains the URA3 gene, and it directs synthesis of a fusion protein that
contains the a-factor receptor lacking codons 297 to 360 and a lysine to arginine change
at position 374 and the green fluorescent protein (GFP) under the control of the STE2
promoter. Plasmid pA Y66 was produced by cloning the PstI/XbaI digest of PCR product
obtained from template pA Y61 with primers PO-271
(GAGACTGCAGATGA TATAGAGAGAAA TCAGTTTT ATCAGTTGCCC) and PO-
into the 5 kb PstI/XbaI digestion fragment of pA Y61. Integrating plasmid pA Y67
contains the URA3 gene, and it directs synthesis of a fusion protein that contains the
factor receptor lacking codons 297 to 360 and a lysine to arginine change at position
387 and the green fluorescent protein (GFP) under the control of the STE2 promoter.
Plasmid pA Y67 was produced with the Quik Change Site Directed Mutagenesis kit
(Stratagene) according to manufacturer s instructions. The primers used were PO-269
(CACACCT ACGAGTTCAAGAAA TACTAGGATAGGACCG) and PO-270
(CGGTCCT A TCCT AGT A TTTCTTGAACTCGT AGGTGTG). The template was
pA Y61. The integrating plasmid pA Y68 contains the URA3 gene, and it directs synthesis
of a fusion protein that contains the a-factor receptor lacking codons 297 to 360 and
lysine to arginine changes at positions 374 and 387 and the green fluorescent protein
(GFP) under the control of the STE2 promoter. It was produced by cloning the PstI/XbaI
digest of PCR product obtained from template pA Y67 with primers PO-271 and PO-
into the 5 kb PstI/XbaI fragment in pA Y61. Integrating plasmid pA Y83 contains the
URA3 gene , and it directs synthesis of a fusion protein that contains the green fluorescent
protein (GFP) and a mutant version of the a-factor receptor that lacks codons 297 to 360
and is truncated at position 391 under the control of the STE2 promoter. Plasmid pA Y83
was created by cloning the ClaI/SacII fragment of PCR product obtained from template
pA Y61 with primers PO-274
(GCGGCCCGCGGCT A TCCT AGT ATTTTTTGAACTCGT AGGTGTGGGCAA) and
PO- 3 (GCAGTTCGATAGTTTCC) into the 5 kb ClaI/SacII fragment ofpAY61.
Integrating plasmid pA Y84 contains the URA3 gene, and it directs synthesis of a fusion
protein that contains the green fluorescent protein (GFP) and a mutant version of the
factor receptor that lacks codons 297 to 360 and is truncated at position 399 under the
control of the STE2 promoter. Plasmid pA Y83 was created by cloning the ClaI/SacII
fragment of PCR product obtained from template pA Y61 with primers PO-275
(GCGGCCCGCGGCGT AACTTGCA TCAGCAAACGGTCCT A TCC) and PO-3 into
the 5 kb ClaI/SacII fragment of pA Y61. Plasmid pDJ427 is an episomal plasmid, which
cares GPD promoter inserted into the pRS426 plasmid (Mumberg et aI. , 1995). It also
harbors the yeast TRP i marker. Plasmid pA Y107 is a yeast episomal plasmid which
cares the TRP i gene and a triple-tagged version of Ste2 (HA-Ste2-Ff-HT) with an HA
tag on the N-termnus and FLAG and His tags on the C-termnus which is synthesized
under the control of TDH3 promoter. Plasmid pA Y107 was created in two steps. First,
the BamHI digestion of pNED1(-Cys) was parially digested with SalI and the 1.4 kb
product was cloned into the BamHI/XhoI site in pRS426GPD. Second, the 1 kb
SacI/HpaI digestion product of pDJ439 was cloned into the SacI/HpaI fragment of the
vector obtained from the previous step.
Yeast strains. Yeast strains listed in Table 1 are congenic to strain 381G. Strains
DJ1400- , DJ1403- , DJ1404- , DJ1405-A, DJ1405- , DJ1406- , DJ1408-
DJ1445, DJ1495, DJ1496 and DJ1414-A to DJ1417-A were derived from DJ211-
strains DJ1402- A, DJ1407 - A, and DJ1418- A were derived from A Y 1; strains DJ141O- A
DJ1411-A, DJ1413-A were derived from strain DJ1205- 3; strains DJ1442 , DJ1443
Strain
381G
DJ211-
AY1
DJ1205-6.:3
DJ1204-
DJ1400-
DJ1402-
DJ1403-
DJ1404-
DJ1405-
DJ1406-
DJ1407-
DJ1408- A
DJ1410-
DJ1411-
DJ1413-
DJ1414-
DJ1417-
DJ1418-
DJ1419-
DJ1442
DJ1443
TABLE 1. Yeast strains used in this study.
Genotype
MATa cryl ade2-l his4-580 lys2 trpl tyrl SUP4-
381G leu2 ura3 barl-
DJ211- Ste2-Sl84R
381G ADE2 HIS4 LYS2 TYRl ura3 barl-
381G ADE2 HIS4 LYS2 TYRl TRPl ura3 barl-lste2::LEU2
DJ211- STE2::pDJ466
DJ211- Ste2-Sl84R::pDJ466 containing plasmid pJBK008
DJ211- STE2::pDJ466 containing plasmid pDJ323
DJ211- STE2::pDJ379
DJ211- ste2-Sl84R::pDJ379
DJ211- STE2::pDJ379 containing plasmid pDJ123
DJ211- ste2-Sl84R::pDJ379 containing plasmid pYe(CEN3)30
DJ211- STE2::pDJ466 containing plasmid pYe(CEN3)30
DJ1205- STE2::pDJ467 containing plasmid pYe(CEN3)30
DJ1205- STE2::pDJ467 containing plasmid pDJ123
DJ1205- STE2::pDJ379 containing plasmid pYe(CEN3)30
DJ211- ura3::pDJ338 STE2::pDJ466
DJ211- STE2::pDJ470 containing plasmid pDJ469
DJ211- Ste2-Sl84R::pDJ466 containing plasmid pDJ323
DJ211- STE2::pDJ466 containing plasmid pJBK008
DJ213- ura3::pDJ338-
DJ213- ura3::pDJ338-
TABLE 1. continued.
Strain Genotype
DJ1445
DJ 1448
DJ211- ura3::pDJ338-
DJ213- , containing plasmid pDJ427
DJ1449
DJ1460
DJ213- 3, containing plasmid pAY107
DJ1204- ura3::pA Y60
DJ1461
DJ1462
DJ1204- ura3::pAY61
DJ1204- ura3::pA Y62
DJ1466
DJ1467
DJ1204- ura3::pAY66
DJ1204- ura3::pA Y67
DJ1468
DJ1483
DJ1204- ura3: :pA Y68
DJ1204- ura3::pA Y83
DJ1484
DJ1494
DJ1204- ura3::pA Y84
DJ213- ura3::pDJ338
DJ1495
DJ1496
DJ211- STE2::pDJ466 ste4::pEL36
DJ211- STE2::pDJ439, containing plasmid pNED1(-Cys)
FY70/pDA6300 Mata leu2!Jl containing plasmid pDA6300
a All strains are congenic with strain 381G (Harwell, 1967).
b Mutation barl- inhibits a-factor degradation (Sprague and Herskowitz , 1981).
Temperature-sensitive mutation SUP4- suppresses amber mutations his4-580 and trpl 
C..sTE2: :pDJ466 ste2 - Sl84R: :pDJ466, STE2: :pDJ379, ste2- Sl84R: :pDJ379,
STE2::pDJ467, STE2::pDJ470, ura3::pDJ338, ura3::pDJ338- , ura3::pDJ338- 16,
i :
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TABLE 1. continued.
ura3::pA Y61 ura3::pA Y62 ura3::pA Y66 ura3::pA Y67 ura3::pA Y68 ura3::pA Y83,
ura3::pA Y84 result in the production of Ste2- , Ste2-S184R- , Ste2-GFP
Ste2-S184R-GFP, Ste2-T326-GFP , Ste2-T326- , Ste2-GFP, Ste2-8(297-360)-GFP
Ste2-8(297 -391 )-GFP, Ste2-8(297 -360)- K37 4R -GFP, Ste2-8(297 -360)- K387R-GFP
Ste2-8(297 -360)- K374R/K387R-GFP , Ste2-8(297 -360)-GFP- T391
Ste2-8(297-360)-GFP-T399, respectively. The CEN plasmids pJBK008 , pDJ323,
pDJ123 and pDJ469 result in the production of Ste2, Ste2-S184R, Ste2 , and
Ste2-T326-GFP, respectively. pYe(CEN3)30 and pDJ467 are control plasmids that
contain the TRP 1 marker. The yeast episomal plasmid, PDA6300, results in the
production of a-factor.
DJ1448, DJ1449 and DJ1494 were derived from strain DJ213- 3; strains DJ1461
DJ1462, DJ1466, DJ1467 , DJ1468, DJ1483 and DJ1484 were derived from strain
DJ1204-2 by transformation with the plasmids indicated in Table 1. Plasmids pDJ379
and pDJ466 were digested with Pst! and plasmids pDJ467 and pDJ470 were digested
with ClaI and Ec047III respectively, prior to transformation to target the integration at
the STE21ocus. Plasmids pDJ338 , pA Y61 , pA Y62, pA Y66, pA Y67 , pA Y68, pA Y83
and pA Y84 were digested with StuI to target the integration at the URA3 locus.
Digestion of plasmid pEL36 with EcoRI resulted in the replacement of the STE4 gene
with URA3. Production of relevant proteins was confirmed by western blotting. Single
integration events were confired by PCR. Strains DJ141O- , DJ1412-A and DJ1413-
were constructed by standard genetic crosses. Yeast strains were transformed with
plasmids by using standard techniques (Soni et aI., 1993). Strain A Y1 (provided by Amy
Yang) was constrcted by subcloning the ste2-S184R allele into integrating plasmid
pDJ251 and then introducing it into the chromosomal locus of strain DJ211- 3 by using
the two-step gene replacement described previously (Schandel and Jenness, 1994).
Culture media. Liquid and solid media were prepared as previously described (Jenness
et aI. , 1997). YM- 1 is a rich liquid medium (Harwell, 1967). Minimal selective media
lacking uracil (-Ura+CAA) or lacking trptophan (-Trp+CAA) are described elsewhere
(Hischman et aI. , 1997). The low sulfate medium has been described previously
(Jenness and Spatrck, 1986).
Antisera and reagents. Rabbit polyclonal antisera were specific for GFP (Seedorf et aI.
1999), for Escherichia coli aspartate transcarbamoylase (ATCase) (from Y. R. Yang and
H. K. Schachman) or for the carboxy-termnal portion of the a-factor receptor, Ste2
(Konopka et aI. , 1988). Mouse monoclonal antibodies that recognize the yeast plasma
membrane ATPase (Pma1) were from clone C56 (Ars and Blobel, 1988; Schandel and
Jenness , 1994). Mouse monoclonal antibodies that recognize the influenza hemagglutinin
epitope (HA.11) were from BAbCO, Berkeley Antibody Co., Richmond, CA.
Peroxidase-conjugated goat anti-rabbit secondary antibodies were purchased from Life
Technologies Inc. , Baltimore, MD. Peroxidase-conjugated goat anti-mouse secondar
antibodies , purified mouse immunoglobulin and n-dodecyl ~-D-maltoside were from
Sigma Chemical Co. , St. Louis , MQ. Purified bovine serum albumin (BSA) was
purchased from Boehrnger Mannheim Co. , Indianapolis , IN. Peroxidase-conjugated
goat anti-mouse and goat anti-rabbit F(ab'h fragment specific IgG were purchased from
Jackson Immunoresearch Inc. , West Grove, PA. The chemiluminescence kit Super
Signal and Ultralink Immobilzed Protein A beads were from Pierce Chemical Co.,
Rockford, IL.
Renografin density gradients. Cultures were grown in -Ura+CAA or in -Trp+CAA
media depending on the plasmid markers used. Membranes were resolved in Renografin
density gradients as previously described (Schandel and Jenness , 1994).
Immunoblotting and quantitation. Western blotting procedures and quantitation were
cared out as previously described (Hirschman et aI., 1997).
Immunoprecipitation. Celllysates were prepared as described previously (Schandel
and Jenness, 1994). Membranes were collected by centrifugation (Beckman airfuge at 28
psi for 20 min , or SW50 rotor at 40 krm for 90 min). The pellet containing the
membranes was suspended in ice-cold IP buffer (50 ro Tris-Cl (pH 7.4), 150 ro NaCl,
5 mM EDTA, 2 mg/ml n-dodecyl ~-D-maltoside (DBM), 10% glycerol, 1 ~g/ml PMSF
1 ~g/ml pepstatin A) and incubated on ice for 2 hours with occasional mixing. The
solution was then centrfuged at 13 000 x g for 5 minutes to remove insoluble material.
In each experiment, equivalent number of cells was processed for each
immunoprecipitation reaction , however, for the experiments in which the cultures had
been treated with a-factor; the extracts were corrected for protein concentration. BCA
(bicinchoninic acid) protein assay (Pierce Chemical Co., Rockford, IL) was used
according to manufacturer s instructions. Precipitating antibodies were added to the
supernatant, and the mixture was incubated at 4 C with gentle agitation for 2 hours.
Protein A beads were added, and the mixture was incubated for 2 hours at 4 C. The
beads were allowed to settle for 5 min, and then collected by centrifugation 1100 x g for 5
seconds. Beads were washed 4 times with IP buffer and extracted with 2x SDS sample
buffer for 10 min at 37 C. Samples were centrifuged at 13,000 x g for 5 min. The
proteins were resolved on 10% SDS-P AGE gels and detected by using immunoblotting
methods. Peroxidase-conjugated goat anti-mouse or goat anti-rabbit F(ab'h fragment
were used as the secondar reagent. The results were quantified by using laser-scanning
densitometry (Molecular Dynamics).
Glycerol gradient sedimentation. 2 x 10
9 cells were collected from exponentially
growing cultures that had been untreated or treated with 10
7 M a-factor for 5 min.
Crude membranes were extracted with D~M as described in the previous section. The
extract was cleared by centrifugation for 15 min at 13,000 x g and mixed with 4.5 ~g
BSA (4.3S), 5 ~g mouse IgG (7S), 10 ~g ATCase (11.7S) as internal marker proteins.
The mixture was applied to an 8-30% glycerol gradient in IP buffer and centrifuged in an
SW50 rotor at 40 krm for 14 h at 4 C. Fourteen 350 ~l fractions were collected assayed
by using SDS-P AGE and immunoblotting methods.
Fluorescence microscopy. Cultures were grown overnight at 34 C to a density of
2 x 10
6 cells/ml in - Trp+CAA medium. 
These conditions provided selection of the
plasmids bearng the TRP 1 gene. Cultures , which did not require selection by TRP1
gene, were grown to a density of 107 cells/ml in YM- 1. Cells were collected and
resuspended in the same volume of YM- 1 media, and then cultured at 30 C to a density
of 10
7 cells/ml. Cultures received cycloheximide (10 ~g/ml) for 5 min and were then
incubated at 30 C for 15 min in the presence or in the absence of a-factor (10 7 M).
Endocytosis was termnated by chiling the cells and adding the metabolic poisons, NaN 
(10 mM) and KF (10 mM). Cells were collected by centrifugation, washed with ice-cold
phosphate-buffered saline (PBS) and suspended in 1/10 volume PBS. Epifluorescent
images were obtained with a Nikon microscope equipped with a cooled CCD camera.
FM4-64 staining. Cultures (strain DJ1413-A) was grown overnight in -Trp+CAA
medium as described above. 2 x 108 cells were collected, suspended in 1 ml ice-cold
YM- 1 containing the lipophylic dye FM4-64 (40 ~M) with or without a-factor (10 7 M)
and placed on ice water for 30 min to allow the dye to bind the cell surface. Cells were
then collected by centrifugation, resuspended in ice-cold YM - 1. Aliquots were removed
from ice and placed in water at room temperature for the times indicated and then placed
back on ice. Cells were collected, resuspended in ice-cold phosphate-buffered saline
analyz d by fluorescence microscopy as described above.
Crosslinking assays. Cultures were grown overnight to a final density of
1- 2 x 10
7 cells/mi. Cells were untreated or treated with a-
factor as described in each
figure. Celllysates were prepared in phosphate-buffered saline supplemented with
protease inhibitors (100 ~g/ml PMSF, 10 ~g/ml pepstatin A) by the method described
previously (Schandel and Jenness, 1994). The protein amounts were determined by BCA
(bicinchoninic acid) protein assay as mentioned above. Lysates containing equivalent
amounts of protein were treated with 0, 2.5 or 5 mM of a thiol-reversible, water-soluble
amine-reactive homobifunctional crosslinkng agent DTSSP dithio-bis-
(sulfosuccinimidylpropionate) (Pierce Chemical Co.) which was freshly prepared as a 50
mM stock solution in 5 mM sodium citrate, pH 5. Following 2 hours of incubation on
ice , the crosslinkng reactions were quenched by the addition of 1/4 volume of 1 M Tris
buffer, pH 7.4. The lysates were then diluted in SDS sample buffer in the presence or in
the absence of reducing agents (50 mM DTT or 100 mM ~ME), subjected to SDS-P AGE
and analyzed by western blotting as previously described (Hirschman et aI., 1997).
Purification procedure for protein complexes containing tagged a-factor receptor.
Cleared celllysates were prepared as previously described (Schandel and Jenness , 1994).
Protein concentrations were determned by BCA (bicinchoninic acid) protein assay, as
described above. Crosslinking reaction was cared out as described in the previous
section. 350 ~l of the lysate with protein concentration of 0.4 mM was used. The
DTSSP concentration was 4 mM. The crosslinked lysates were mixed with 76%
Renografin to give a 1 mllayer with final Renografin concentration of 42%. 4 ml of 34%
Renografin was layered on top. The two-step gradient was centrifuged in an SW-50 rotor
at 40,000xrpm (4 C) for 15 hr. A 750 ~l sample from the top, which contains the
cellular membranes , was collected. The membrane fraction was diluted with 4 ml of
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phosphate-buffered saline and pelleted by centrifugation at 40,000 x rpm (4 OC) for 2 hr.
The pellet containing cell membranes was incubated in 0.2 ml IP buffer for 2 hr on ice to
extract the membrane proteins. The reaction was centrifuged at 13,000 x g in a
microfuge, and 2 ~g of anti-HA antibodies was added to the supernatant. The
immunoprecipitation reaction was carried out as described above except after the last
wash, the pelleted Ultralink Protein A Plus beads were washed with IP buffer without
EDT A, and precipitated proteins were extracted by the addition of Urea-Nt binding
buffer (8 M urea, 500 mM NaCl, 5 mM imidazole, 20 mM Tris, pH 8.0) in three
sequential applications (100 ~l each). The extracted material was then incubated with
Ni+ NTA beads (Qiagen Inc.) that had been precycled in Urea-Ni+ binding buffer. The
reaction tube was rotated end-over-end for 5 h at room temperature. The beads were then
washed four times with Urea-Nt binding buffer, once with Urea-Nt binding buffer with
150 mM NaCl and twice with Urea-Nt binding buffer with no NaCl and no imidazole.
The bound material was either eluted with SDS sample buffer and resolved on
one-dimensional SDS-PAGE or processed as described below for two-dimensional gel
electrophoresis.
Two-dimensional gel electrophoresis. The material obtained at the end of the 2-step
purification procedure was processed for two dimensional electrophoresis by first
extracting the bound proteins with 63 ~l of solubilzing mixture (8 M urea, 2% CHAPS
4% ~ME) and then by extracting the beads again with 190 ~l of the solubilizing mixture
supplemented with DTT (3 g/l) , Pharalyte (1 % v/v) and IPG buffer (1 % v/v)
(Pharacia). The two extracts were pooled to obtain the 'rehydration mixture . IPG
strips with a pH range of 3-to-9 were used. Strips were each placed on top of 250 ~l
rehydration mixture. The rehydration was allowed to proceed for about 17 hr at room
temperature. The 2D gel electrophoresis was performed according to manufacturer
instructions (Pharacia).
Silver staining. SDS gels were fixed for 30 min or overnight in 50% ethanol, 10% acetic
acid, 40% Mill-Q water. Gels were incubated in 30% ethanol for 15 min and washed
three times for 5 min with Mili-Q water. Gels were sensitized with freshly prepared 0.
g/L sodium thiosulfate for 1.5 min and washed three times for 30 sec with Mili-Q water.
In the staining step, gels were soaked in 2 g/L silver nitrate for 25 min and washed twice
with 2 to 3 L of Mill-Q water. Gels were developed in 60 g/L sodium carbonate, 20
ml of the sodium thiosulfate solution from the sensitization step and 500 ~l/ of 37%
formaldehyde in Mili-Q. The development was stopped by removing the developing
solution and adding 6% acetic acid in Mili-Q water for 10 min. Gels were then washed
for a minimum of 4 changes of Mili-Q water with 15 min intervals each and the band of
interest was cut out.
Purifcation of labeled a-factor. The strain FY70/pDA6300 was grown overnight at
C to a density of 5 X 10
6 cells/rn in 20 
rnlow sulfate medium (20 ~M NaS0 ) or
LSM+S0 . 6X 107 cells were collected, washed with 12 rn LSM with no added sulfate
and suspended in 12 rn LSM+20 ~M NaS0 . 25 mCi of S04 was added to the
culture. The culture was incubated at 30 C with shakng until the cells incorporated 89%
of the label. The cells were collected by centrifugation. The supernatant was
supplemented with p-tosyl-L-arginine methyl ester (TAME) to a final concentration of
10 mM and ~-mercaptoethanol (~ME) to a concentration of 2 mM. The supernatant was
then loaded onto a 2.5 rn Bio-Rex 70 column that had been precycled in 0. 1 N acetic
acid and 2mM ~-mercaptoethanol (~ME) at 4 C. The column was washed with 4 column
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volumes of Wash 1 (0. 1 N acetic acid and 2mM ~ME) and then with 4 column volumes of
Wash2 (50 % ethanol, 0. 1 N acetic acid, 2 mM ~ME). The radiolabeled a-factor was
eluted with 4 column volumes of 80 % ethanol, 0.01 N HCl, 2 mM ~ME. 60 ~l of 1M
Tris , pH8 was added to each of 2.5 ml fractions. 3 ~l of each fraction was counted in a
scintilation counter and the amount of label in each fraction was determined. Halo
assays were performed on all fractions. Known concentrations of synthetic a-factor
(Sigma Chemical Co.) were included as standards diluted in 80 % ethanol. A
supersensitive strain (6360- 17-2) was used. The percent binding activity was determned
by incubating labeled a-factor with a large excess of a STE2+ strain and separately with
ste2/J cells that had been poisoned with 10 mM NaN and KF. The incubation time was
15 min at room temperature. Cells were collected by centrifugation and radioactivity in
each supernatant was determned. The percentage of labeled material that was active was
calculated as follows:
% active = ( (cpm in ste2/J sup) - (cpm in STE2+ sup) ) / (cpm in ste2/J sup) x 100
Overall, I obtained 5 ml of 2 x 1O 1abeled a-factor with a specific activity of
63 Ci/mmol.
Downregulation assays. Cultures were grown overnight at 30 C to a density of
1- 2 X 10
7 cells/ml and then diluted to 5 X 106 cells/ml in the presence of 10 mM TAME.
Cultures were then incubated with 1 0 ~M cycloheximide in the presence or in the
absence of 1O M unlabeled a-factor. At the times indicated, 25 ml aliquots were filtered
on presoaked nitrocellulose filters and washed twice with 2 ml Inhibitory Medium (1M)
which contained YM- 1 in 10 mM NaN , 10 mM KF and 10 mM TAME. The cells that
had been collected on the fiter were suspended in 10 mlIM , and the bound unlabeled
factor was allowed to dissociate. The cells expressing wild-type receptors were
incubated for 2 hours at room temperature, and the strains expressing Ste2 internal
deletion mutants were incubated in a 30 C water bath for 4 h. It has been previously
determned that incubation for 2 h at room temperature was sufficient for the dissociation
of pre bound a-factor from cells expressing Ste2, whereas strains expressing a
severely-truncated receptor (Ste2- T326) required 4 hours at 30 C to allow for ::90%
dissociation (Schandel and Jenness , 1994). Cells were collected by centrifugation and
resuspended in 0.5 ml 1M and held on ice overnight. 90 ~l samples of cells were added
to four tubes. Two tubes contained 10 ~llabeled a-factor (2X 10 M). The other two
tubes contained a mixture of labeled a-factor (2 x 10 7 M) with an excess of unlabeled
factor (2X 10 5 M). After 30 min of incubation at C, 90 ~l samples removed to 2
ml 1M and immediately collected on prewetted GF/C filters. Filters were washed twice
with 2 ml 1M. Washing time was between 0.4- 5 min. Dried fiters were counted in
toluene-omnifluor scintilant for 5 min with a liquid-scintilation counter. The counts
obtained from duplicate fiters were averaged. The binding activity at each time point
was determned by subtracting the cpm values obtained from binding reactions that
contained excess unlabeled a-factor from those that contained labeled a-factor-only. The
percentage of receptor remaining on cell surface was determned by dividing the binding
activity at each time point by the binding activity determned at time zero for the given
strain.
Protein turnover assays. Cultures were grown overnight to a density of
2x 10
7 cells/ml. Cycloheximide was added to a final concentration of 10 
~g/ml.
Samples were withdrawn at times indicated. Celllysates were prepared, the amount of
total protein in each sample was determned, and samples were processed for SDS-PAGE
and western blotting as described above. Approximately ' 1 ~g of protein per lane was
loaded onto duplicate gels per each sample. The samples obtained at the zero time point
were loaded at 0.5 and 1 ~g per lane to assess the linearty of the assay. Two separate
autoradiographic exposures obtained from each gel were quantified by using
laser-scanning densitometry (Molecular Dynamics). The scanning results obtained from
the zero time point lanes loaded with 1 ~g protein were compared with the results from
the same samples that had been loaded with half the amount. The exposure in which the
ratio was closest to 1/2 (within a range of 1/3 to 2/3) was used. Results obtained from the
two independent experiments were averaged.
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OLIGOMERIZATION OF THE a-FACTOR PHEROMONE RECEPTORS
Many cell surace receptors are organzed in multieric complexes. For certain
receptors (e.g. JAK family receptors and receptor tyrosine kinases), such higher order
structues provide higher ligand binding afnity and induce receptor activation and therefore
contrbute to the strcture and function of these receptors. Until recently, members of
protein-coupled receptor superfamly (GPCRs) were assumed to function as monomers.
However, early observations suggested oligomerization of GPCRs. Some examples include
allelic complementation of coexpressed mutant receptors (Konopka and Jenness, 1991), and
the presence of large SDS-resistant receptor-protein aggregates on SDS-P AGE gels
(Blumer et al. , 1988; Herberg et al., 1984; Konopka et al., 1988; Ng et aI. , 1993). More
direct evidence was obtaned recently by using fluorescence resonance energy transfer
(FRT), crosslinkng and coimmunoprecipitation approaches, suggesting oligomerization of
the ~2 adrenergic (Hebert et al., 1996), 8-opioid (Cvejic and Devi, 1997), D2 and D3
dopamne (Ng et aI. , 1996; Nimchinsky et al. , 1997), m3 muscarnic (Zeng and Wess
1999), metabotropic glutamate (Romano et aI. , 1996) and Ca -sensing receptors (Bai et aI.
1998).
While oligomerization is emerging as a common theme for GPCRs , our
understanding of this phenomenon is limited. The influence of agonists on receptor
oligomerization and the strctual determnants of the receptor that are important for
oligomerization have been shown to var among the GPCRs investigated. For example
agonists appear to stabilze dimers of ~2 adrenergic receptors (Hebert et al.
, 1996), whereas
agonist binding favors the monomeric state of 8 opioid receptors (Cvejic and Devi
, 1997)
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and fails to alter the oligomeric state m3 muscarnic receptors (Zeng and Wess
, 1999).
Transmembrane region VI is thought to mediate the association of ~2-adrenergic receptors
since peptides containing this sequence interfere with the recovery of receptor dimers and
interfere with signaling (Hebert et aI. , 1996). In contrast, a 15 amno acid sequence
contained in the C-termnal tail of 8-opioid receptor has been associated with dimerization
(Cvejic and Devi, 1997), and the Ca
-sensing receptor and metabotropic glutamate receptor
5 oligomers are linked covalently through disulfide bonds (Bai et al.
, 1998; Romano et aI.
1996) .
Functional significance of GPCR oligomerization is currently unclear. Functional
interactions between oligomerized receptors have been inferred from the cooperative binding
of subtype-specific ligands to receptor heterodimers containing 8- and K-opioid receptors
(Jordan and Devi, 1999). The relationship between oligomerization and signal transduction
is controversial. A peptide derived from the transmembrane of the ~2-adrenergic receptor
results in the reduction of receptor dimers detected and the receptor signaling activity
(Hebert et al. , 1996). In contrast, the corresponding region of the D1 dopamine receptor
inhbits receptor signaling activity without affecting oligomerization (George et al. , 1998).
For the 8 opioid receptor, ligand-induced dissociation of receptor oligomers is found to
precede ligand-mediated endocytosis (Cvejic and Devi, 1997). Ths correlation suggests
that the dissociation of oligomers may be an essential step in the endocytic pathway.
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Oligomerization of a-factor receptors in the plasma membrane was fIrst proposed
by Jenness and Spatrck (1986) since receptors were internalized more rapidly than bound
factor at subsaturating a-factor concentrations. In ths chapter, I sought to determne
whether yeast a-factor receptors form oligomers and whether oligomers are subject to
ligand-mediated endocytosis.
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Results
Immunoprecipitation of differentially-tagged receptors
Interactions between a-factor receptors were evaluated by performng
coimmunoprecipitation experiments with differentially-tagged receptors that had been
solubilized with the non-denaturing detergent n-dodecyl ~-D-maltoside. We examned cells
that express a-factor receptors tagged with the influenza hemagglutinin epitope (Ste2-HA)
as well as a-factor receptors tagged with the green fluorescent protein (Ste2-GFP). Both
epitope tags were fused to the receptor after the C-termnal residue. The genes encoding the
two fusion proteins were present in single copy and utilized the native STE2 promoter.
Crude membranes were prepared and extracted with the detergent. Glycerol gradients were
performed to evaluate the size and the homogeneity of the complexes containing receptors.
Both Ste2-HA and Ste2-GFP sedimented as a single peak with sedimentation coefficient of
roughly 8S in glycerol density gradients (Fig. 1A), although Ste2-HA sedimented slightly
faster than Ste2-GFP. Similar results were obtained when the cultures had been exposed to
factor (Fig. 1B). Both Ste2-HA and Ste2-GFP were found to coimmunoprecipitate
when the receptors in the detergent extract were precipitated with anti-HA antibodies and
analyzed with immunoblotting methods using antisera specific for C-termnus of the
receptor (Fig. 2A, lane 3). The two tagged species were resolved on the blot since
Ste2-GFP is significantly larger than Ste2-HA (80 kDa versus 55 kDa, respectively). No
precipitation of Ste2-GFP was detected in the analysis of the control cells that expressed
only Ste2-HA or only Ste2-GFP (Fig. 2A, lanes 1 and 2, respectively).
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Figure 1. Glycerol gradient sedimentation. Membrane proteins from strain DJ1414-
were solubilzed in IP buffer containing n-dodecyl ~-D-maltoside and then resolved on a
30%' glycerol gradient. Cultures were untreated (A) or treated with 10- M a-factor for 5
min (B). Fractions were assayed for Ste2-HA (0) and Ste2-GFP (8) and for marker
proteins , BSA (4.3S), mouse IgG (7S) and ATCase (11.7S).
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Figure 2. Imunoprecipitation of differentially-tagged receptors. Cells that expressed one
or two tagged forms of the receptor (Ste2-HA and Ste2-GFP) were analyzed. Membrane
proteins extracted with n-dodecyl ~-D-maltoside were subjected to immunoprecipitation and
then analyzed by using immunoblotting methods. The antibodies used for precipitation and
for immunoblotting are denoted below each panel ("IP" and "Probe , respectively). As
indicated above each lane, the cells analyzed expressed Ste2- , Ste2-GFP or both.
(A) Anti-HA antibody precipitates Ste2- , Ste2-GFP and SDS-resistant dimers.
(B) Effciency of Ste2-GFP precipitation with anti-HA antibody. Lanes 1-4 contained
10% of the immunoprecipitated protein (pellet). Lanes 5-8 contained 2.5% of the
unprecipitated protein (supernatant). Cells expressing both Ste2-HA and Ste2-GFP were
either untreated or treated with 10- M a-factor for 5 min prior to analysis. (C) Effciency
of Ste2-HA precipitation with anti-GFP antibody. Lanes 1-3 contained 17% of the
immunoprecipitated protein (pellet). Lanes 4- contained 1 % of the total protein (input).
(D) Coprecipitation does not result from processing of the samples after cell lysis. Lanes
, processed as in panel B. Lane 4, the cells expressing only Ste2-HA were mixed prior
to lysis with the cells expressing only Ste2-GFP. The same blot was sequentially probed
with anti-GFP (top panel) and anti-HA antibody (bottom panel). (E) Plasma membrane
ATPase is not present in immunoprecipitates containing Ste2-HA. Strains were DJ1400-
(Ste2-HA only), DJ1404-A (Ste2-GFP only), DJ1414-A (Ste2-HA/Ste2-GFP) and
DJ211- 3 (Ste2).
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Two protein species containing Ste2 were detected that had molecular weights
greater than 100 kDa (Fig. 2A , lanes 1 and 3). Such high molecular weight forms
designated "SDS-resistant dimers , are commonly observed when analyzing Ste2 and
other GPCR proteins (Blumer et al. , 1988; Hebert et al., 1996; Konopka et al. , 1988).
However, the proportion of receptors that migrated as SDS-resistant dimers was varable
among different preparations. In earlier work, it has been unclear whether ths high
molecular weight species reflects the aggregation of Ste2 with itself or with other proteins,
and it has also been unclear whether it represents receptor dimers present in the membrane
or dimers that arse only after SDS extraction. Interestingly, a single high molecular weight
protein was detected from cells expressing Ste2-HA alone (Fig. 2A, lane 1), consistent with
Ste2-HA dimers, whereas cells expressing both Ste2-HA and Ste2-GFP produced bands
consistent with Ste2-HNSte2-GFP hetero-dimers in addition to Ste2-HA homo-dimers
(Fig. 2A , lane 3). The absence of Ste2-GFP homo-dimers is expected because the samples
had been immunoprecipitated with anti-HA antibodies, therefore only Ste2-HA and
Ste2-GFP heterodimers and Ste2-HA homodimer were expected to precipitate. Ths
observation furter implies that the SDS-resistant dimers did not form in the SDS sample
buffer. If the SDS-resistant dimers were formed following extraction by SDS , then the
Ste2-GFP molecules that dissociated from Ste2-HA would also have formed SDS-resistant
homo-dimers. These observations indicate that an SDS-resistant dimer contains more than
one molecule of Ste2.
As a more defined method of evaluating coimmunoprecipitation of Ste2-HA and
Ste2-GFP, I performed reciprocal immunoprecipitation experiments. Antibodies against
one epitope were used to precipitate receptors from the detergent extract, and then antibodies
against the second epitope were used to test for the presence of the second tagged species in
the immunoprecipitate. In Fig. 2B , anti-HA antibodies precipitated 11 % of the Ste2-GFP
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from the extracts of cell expressing both receptors (compare lanes 3 and 7), whereas no
detectable Ste2-GFP was precipitated from the control cell extracts contaning only
Ste2-GFP or only Ste2-HA (lanes 1 and 2, respectively). Similar results were obtained
when the cultures had been exposed to a-factor for 5 min (lanes 4 and 8, see also lanes 
and 3) prior to the analysis. In the reciprocal experiment (Fig. 2C), anti-GFP antibodies
precipitated about 6% of the Ste2-HA from the extracts of cell expressing both receptors
(compare lanes 3 and 6), and no Ste2-HA was precipitated from either control extract (lanes
1 and 2). Again, prior exposure to a-factor for 5 min had no discernable effect. In both
experiments, the antibody used for immunoprecipitation cleared all the antigen from the
supernatant. Similar results were obtained using two other detergents, 1 % TritonX - 100 and
1 % C12E8 suggesting that the interactions detected within the receptors are not specific to
dodecyl ~-D-maltoside (Fig. 3). To test whether the possibilty that the oligomerization 
induced at a later step, I performed immunoprecipitation experiments with cells that had
been exposed to a-factor for up to 15 minutes. Receptors are normally depleted from the
plasma membrane after 15 min under the conditions used (see Fig. 6A). Comparable
amounts of Ste2-GFP coimmunoprecipitated with Ste2- HA from cells that had been treated
with a-factor for 5, 10, 15 minutes (Fig. 4B). Similar results were obtaned when anti-GFP
antibodies were used and blots were probed with anti-HA antibodies (Fig. 4D). In both
experiments, results from control blots indicated that equivalent amounts of Ste2-HA and
Ste2-GFP precipitated with anti-HA and anti-GFP antibodies, respectively (Fig. 4A and
4C). Therefore, when the efficiency of coimmunoprecipitation of differentially-tagged
receptors was used as a measure, the extent of receptor oligomerization was unchanged
when1Je cultures had been exposed to a-factor for 15 minutes before analysis (Fig. 4).
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Figure 3: Coimmunoprecipitation of differentially tagged receptors in thee different non-
ionic detergents. Cells expressing one or both forms of the tagged receptor were analyzed.
Membrane proteins extracted with 0.2% D~M (lanes 1 and 4), 1 % C12E8 (lanes 2 and 5)
or 1 % Triton X- 100 (lanes 3 and 6) were subjected to immunoprecipitation by using the
anti-HA antibody. The coimmunoprecipitated protein was analyzed by using
immunoblotting methods with the anti-GFP antibody from strains that expressed only Ste2-
GFP (lanes 1-3) or both Ste2-HA and Ste2-GFP (lanes 4-6). Strains were DJ1404-
(Ste2-GFP) and DJ1414-A (Ste2-HA/Ste2-GFP).
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Figure 4. Factor treatment up to 15 minutes does not affect the levels of receptor
oligomerization. Cultures of cells that expressed two tagged forms of the receptor
(Ste2-HA and Ste2-GFP) were untreated (lane 1 in all four panels) or treated with 10-
factor for 5 , 10 or 15 min (lanes 2 3 and 4, respectively, for all panels). Membrane
proteins that had been extracted with n-dodecyl ~-D-maltoside were subjected to
immunoprecipitation and then analyzed by using immunoblotting methods. The antibodies
used for precipitation and for immunoblotting are denoted below each panel ("IP" and
Probe , respectively). (A) Anti-HA antibody precipitates equivalent amounts of Ste2-
at each time point. (B) Anti-HA antibody precipitates equivalent amounts of Ste2-GFP at
each time point. (C) Anti-GFP antibody precipitates equivalent amounts of Ste2-GFP at
each time point. The asterisk shows the aggregates of Ste2-GFP that are typically detected
upon precipitation of this protein with the polyclonal anti-GFP antibody. (D) Anti-GFP
antibody precipitates equivalent amounts of Ste2-HA at each time point. The strain was
DJ1414-
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Figure 5. Imunoprecipitation of differentially-tagged receptors from glycerol gradients.
The fractions 7 and 8 from the glycerol gradients in Fig. 1 were pooled, subjected to
Blot: aGFP
imm poprecipitation and then analyzed by using immunoblotting methods as in Fig. 2.
(A) Anti-HA antibody precipitates Ste2-GFP from these fractions. (B) Anti-GFP antibody
precipitates Ste2-HA. The strain was DJ1414-
Coprecipitation of Ste2-HA and Ste2-GFP was not a consequence of incomplete
membrane solubilization or nonspecific aggregation of membrane proteins. The
coprecipitated Ste2-HA and Ste2-GFP were apparently par of the 8S complex since
essentially all of Ste2-HA and Ste2-GFP extracted under these conditions sediments
approximately as an 8S species (Fig. 1A). Moreover when the 8S peak in Fig. 1A was
pooled and analyzed according to the reciprocal immunoprecipitation method, about 5% of
Ste2-GFP was precipitated with anti-HA antibody and 5% of Ste2-HA was precipitated with
anti-GFP (Fig. 5). In addition, the protein complexes containing Ste2 do not appear to
result from nonspecific aggregation of membrane proteins since the more abundant
transmembrane protein, plasma membrane ATPase (Pma1) was not found in
immunoprecipitates containing Ste2-HA (Fig. 2E).
I considered the possibility that receptor complexes that I observed had been formed
only after the proteins were extracted from the membrane with detergent. To test ths
possibility, I mixed cells that only expressed Ste2HA with cells that only expressed
Ste2-GFP and then processed the mixture for immunoprecipitation as above (Fig. 2D).
Ste2-GFP and Ste2- HA coprecipitated only when both receptors were expressed in the
same cells (Fig. 2D, lane 3) but not when the two cultures expressing Ste2-HA and
Ste2-GFP receptors were mixed (Fig. 2D, lane 4). Similar results were obtained when the
cultues had been treated with a-factor for 5 min. Therefore a-factor receptors are present
in the plasma membrane as complexes containing two or more receptor molecules. Failure
to detect any changes in the complexes induced by a-factor pretreatment does not rule out
the pgssibility that a-factor influences higher order states of aggregation that were not
stable in the solvent conditions used.
Ste2-S184R is internalized with the wild-type receptors upon a-factor exposure
Early work with a-factor receptor endocytosis suggested that receptors are
internalized as oligomeric units (Jenness and Spatrick, 1986). When yeast cells are
exposed to subsaturating concentrations of a-factor, the rate at which a-factor-receptor sites
are lost from the plasma membrane is greater than the rate of a-factor uptake. Ths
observation suggests that unoccupied receptors are internalzed together with the occupied
receptors. Thee explanations (not mutually exclusive) account for these phenomena:
(i) binding of a-factor may be necessar only to initiate the events that lead to the
internalzation, i. e., receptor internalzation may proceed even after a-factor dissociates
(ii) the invaginations of the plasma membrane that occur during endocytosis may be large
enough to include both occupied receptors and neighboring unoccupied receptors
, (iii) the
occupied and unoccupied receptors may exist as oligomeric units that remain coupled
during endocytosis. To determne whether a-factor binding is required to initiate receptor
internalzation, wild-type Ste2 and the a-factor-binding-defective mutant, Ste2-S184R were
coexpressed. In the presence of a-factor, these two receptors represent occupied and
unoccupied receptors, respectively. If the internalization of the unoccupied receptors
requires prior occupancy, then endocytosis of Ste2-S184R should not be induced by
factor since it does not bind a-factor. Conversely, if internalzation of unoccupied
receptors reflects cointernalzation, then Ste2-S184R internalization should be stimulated by
factor.
' Membrane fractionation was used to evaluate ligand-induced exit of Ste2-S184R
from the plasma membrane in the presence and in the absence of the wild-type receptor.
Strains that coexpress both wild-type Ste2 and mutant Ste2-S184R receptors were created.
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Figure 6. Binding-defective receptors, Ste2-S184R, undergo ligand-induced endocytosis
when expressed with wild-type receptors. Each of the four strains analyzed expressed an
HA-tagged receptor (Ste2-HA or Ste2-S184R-HA) encoded by a chromosomal allele and
an untagged plasmid-encoded receptor (Ste2 or Ste2-S184R). Log-phase cultures in
Ura+CAA medium were treated with cycloheximide and then cultued for 15 min in the
absence (0) or presence of a-factor (.). Membranes were fractionated by using
Renografin density gradients. Fractions were assayed for HA-tagged receptors (0 .) and
for plasma membrane ATPase (no plot symbol) by using immunoblotting methods. Plasma
membrane marker shown for a-factor-treated cultures only. Protein amount is the
percentage of the total protein. (A) Cells expressing Ste2-HA and Ste2 (strain DJ1419-A).
(B) Cells expressing Ste2-S184R-HA and Ste2-S184R (strain DJ1418-A). (C) Cells
expressing Ste2-HA and Ste2-S184R (strain DJ1403-A). (D) Cells expressing
Ste2-S184R-HA and Ste2 (strain DJ1402-A).
Genes encoding both receptors were present in a single copy and contaned the native STE2
promoter. In each experiment, the chromosomal allele directed synthesis ofHA-tagged
receptors, and a plasmid-born allele diected synthesis of untagged receptors. Exponentially
growing cultures were treated with cyclohexide to block new receptor synthesis
incubated furter either in the presence or in the absence of a-factor, and then after 15 min
the membranes were resolved on Renografin density gradients. Since essentially all of the
receptors were on the cell surace prior to treatment (not shown), receptors detected in
internal membrane fractions represent molecules that have exited the plasma membrane. As
shown previously (Schandel and Jenness , 1994), the cells that expressed only wild-type
receptors internalized essentially all their receptors in response to a-factor, as indicated by a
shift of the Ste2 protein from the denser plasma membrane fractions to the more buoyant
internal membrane fractions (Fig. 6A). In contrast, cells expressing only Ste2-S184R
showed no a-factor-induced internalization (Fig. 6B). Upon a-factor exposure, a
significant fraction of the tagged Ste2-S184R receptors were internalized in cells containing
untagged wild-type receptors (Fig. 6D). This observation suggests that internalization of
f " unoccupied receptors is not a consequence of prior a-factor occupancy since Ste2-S 184R
receptors do not bind a-factor. In the reciprocal experiment, internalization of tagged
wild-type receptors was not influenced by the presence of the mutant Ste2-S 184R receptors
(Fig. 6C).
As a second assay for endocytosis of occupied and unoccupied receptors, I used
fluorescence microscopy to monitor wild-type and mutant receptors that had been tagged
" '
with green fluorescent protein, GFP. Ste2-S184R-GFP was coexpressed with untagged
wild-type receptors to test whether internalization of the wild-type receptors would cause the
' "
internalization of the Ste2-S184R-GFP receptors. As in Fig. 6, cultues that had been
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Figure 7. Ligand-induced internalization of GFP-tagged binding-defective receptors
depends on the presence of wild-type receptors. Cultures were treated with cycloheximide
and a-factor as described in Fig. 3. First two columns are controls lacking a-factor; the
last two columns are a-factor-treated cells. GFP fluorescence images and Nomarski
images are indicated below each column. Top row, cells expressing Ste2-GFP only (strain
DJ1408-A). Middle row , cells expressing Ste2-S184R-GFP only (strain DJ1407-A).
Bottom row, cells expressing both Ste2-S184R-GFP and untagged Ste2 (strain DJ1406-A). .
TABLE 1. Quantitation of fluorescent foci from cells expressing Ste2 and Ste2-S184R
percentage of cells
Ste2 forms expressed factor n;;l n;;3
Ste2-GFP 31 :t 3 7:t 2
Ste2-GFP 94 :t 2 44:t3
Ste2-S184R-GFP 31 :t 3 6:t 1
Ste2-S184R-GFP 57 :t 3 7:t 2
Ste2-S184R-GFP and Ste2 33 :t 3 7:t 2
Ste2-S184R-GFP and Ste2 72 :t 2 32 :t 2
a The forms of Ste2 expressed in each strain are shown. Strains used are, DJ1408-
(rows1 , 2), DJ1407-A (rows 3 , 4), DJ1406-A (rows 5 , 6).
b Fluorescent foci were counted from GFP images of cells treated with cycloheximide and
factor as in Fig. 3. The percentage of cells with one or more fluorescent foci (n;;l) and
the percentage of cells with three or more fluorescent foci (n;3) are indicated for the cells
that had been cultured in the presence or absence of a-factor. More than 200 cells were
examned for each entr.
treated with cycloheximide were challenged with a-factor. In the absence of a-factor, the
cells containing GFP-tagged mutant and wild-type receptors exhbited fluorescence both at
the plasma membrane and in the vacuole. Previous results (Li et al. , 1999) indicate
fluorescence in the vacuole reflects the free GFP that remains after the Ste2-GFP fusion
protein has been endocytosed and the Ste2 portion of the protein degraded. In presence
of a-factor, the wild-type Ste2-GFP was completely removed from the plasma membrane
and appeared as punctate strctures presumably corresponding to endocytic vesicles (Fig. 7,
top row), whereas cells expressing only the Ste2-S184R mutant receptors showed very little
internalization of cell-surface fluorescence (Fig. 7 middle row). In contrast, in cells
expressing both Ste2-S184R-GFP with untagged Ste2 , the plasma membrane fluorescence
was significantly reduced and greater proportion of the fluorescence appeared in internal
punctate strctures (Fig. 7 bottom row). When analyzed quantitatively, 32% of the cells
expressing both Ste2-S184R-GFP and Ste2 showed three or more fluorescent foci after
factor treatment, whereas only 7% of the cells expressing Ste2-S184R-GFP alone
showed more than thee fluorescent foci (Table 1). In addition, coprecipitation of Ste2 and
Ste2-S184R-GFP was observed (Fig. lOA). These observations are consistent with our
results from the Renografn gradients indicating that Ste2-S 184R receptors are internalized
with the wild-type receptors in the presence of a-factor.
Two criteria were used to judge whether endocytosis of occupied receptors results in
the internalization of a significant porton of surrounding plasma membrane and membrane
proteins. First, essentially all of the abundant plasma membrane protein ATPase , Pma1
remain d at the plasma membrane when the cells containing wild-type receptors were treated
with a-factor (Fig. 6). Second, the bulk endocytosis of plasma membranes marked with the
vita stain FM4-64 (Vida and Emr, 1995) was not infuenced by a-factor (Fig. 8). At 8 min
FM4-64 was completely internalized in the presence and in the absence of a-factor
(Fig. 8A , middle row) whereas for the same duration with a-factor, only about 50% of the
factor receptors are depleted from the plasma membrane (Schandel and Jenness , 1994).
Therefore, the rate of uptae of the dye is faster than the rate of internalization of the
receptors. Similar results were obtained at 15 min time point (Fig. 8A, bottom row). I then
wished to investigate the uptake of FM4-64 at earlier time points. A significant portion of
the FM4-64 was internalized after only 2 min, however, the staning pattern was
indistinguishable for the cells that were untreated or treated with a-factor (Fig. 8B). These
results suggest that the endocytosis of unoccupied receptors does not simply reflect an
increased rate of plasma membrane internalization in response to a-factor, and they are
consistent with the hypothesis that unoccupied receptors are endocytosed because they form
oligomeric complexes with occupied receptors. Imunoprecipitation experiments
confIrmed biochemically the formation of oligomers between wild-type and mutat
receptors. When anti-GFP antibodies were used to precipitate Ste2-S184R-GFP receptors
from cells coexpressing both mutat and wild-type receptors, Ste2 antisera against the
carboxy termnus of the receptor detected the untagged wild-type receptors in the
imunoprecipitate pellet.
Wild-type Ste2 causes internalization of endocytosis-defective receptors in the
presence of factor
The C-termnal cytoplasmic tail of Ste2 contans sequence elements that are essential
for both basal and ligand-induced endocytosis (Rohrer et aI., 1993; Schandel and Jenness,
1994). The trncated receptor, Ste2-T326, binds a-factor normally, even though it lacks
most of the C-termnal tal (Konopka et al., 1988). Ths domain contains the
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Figure 8. The dynamcs of the lipophyllc dye uptake in a-factor-treated and untreated
cells. The membrane permeable dye FM4-64 was simultaneously added to cell cultues
with or without 10- M a-factor (left and right columns, respectively). The reactions were
immediately placed on ice. Aliquots were taken out and incubated at room temperatue for
the durations indicated on the left and placed on ice with metabolic poisons. Then the
samples were analyzed by fluorescence microscopy. (A) The dye uptake of cells that had
been untreated or treated with a-factor for 0, 8 and 15 minutes. (B) The dye uptake of cells
that had been untreated or treated with a-factor for 0 and 2 minutes. Strain was DJ1406-
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well-characterized endocytosis motif (DAKSS) (Rohrer et aI., 1993). My next goal was to
determne whether the severe endocytosis defect associated with this mutant receptor could
be overcome by formng oligomers with wild-type receptors. Coimmunoprecipitation of
Ste2-HA and Ste2-T326 was observed when detergent extracts were analyzed according to
the methods depicted in Fig. 1. (Fig. lOB , lane 1). Similar results were obtained when
experiments were conducted with cells that had been exposed to a-factor for 5 minutes
prior to analysis (Fig. lOB , lane 3). Renografn density gradients and fluorescence
microscopy were used to monitor endocytosis of Ste2-T326 tagged with GFP. Table 2
summarzes a-factor-induced internalization of receptors, as judged by Renografn density
gradients. Consistent with previous results (Schandel and Jenness, 1994), Ste2-T326-GFP
levels increased in intracellular membranes due to increased protein synthesis. In Table 2
and in the previous study (Schandel and Jenness, 1994), a small number of the trncated
receptors (17.6%) cofractionated with the internal membranes, and ths quantity decreased
slightly (to 13.5%) in the cells that had been exposed to a-factor. However, under these
conditions, a-factor resulted in a nearly five-fold increase in the accumulation of
Ste2- T326-GFP in the internal membrane fraction when Ste2- T326-GFP and wild-type
Ste2 were coexpressed. Ths result is consistent with the endocytosis of oligomeric
complexes containing trncated and wild-type receptors. It is currently unclear why some
of the trncated receptors accumulate in the internal membrane pool, and why ths quantity
decreases when trncated and wild-type receptors are coexpressed. As has been proposed
for CCR5 receptors (Benkrane et al. , 1997), it is possible that the trncated a-factor
receptors are parially retained in the ER and that the defect is overcome by formng
oligomers with the wild-type receptors.
TABLE 2. Wild-type receptors cause trncated receptors to be internalized in presence of
a- factor
Percentage of receptors in internal membranes
Strain Ste2 forms expressed
( -
) a- F
( +) 
a- F
DJ1413- Ste2 7 :t 2. 86.2 :t 2.
DJ141O- Ste2- T326 17.6:t 6. 13.5 :t 5.
DJ1411- Ste2- T326 and Ste2 7 :t 2. 23 :t 2.
DJ1411- Ste2-T326 and Ste2 24.7 :t 10. 73.2:t8.
a The Ste2 forms expressed in each strain are shown. For each entry, the Ste2 form that
was assayed is marked in bold-type and underlined.
b Cells were processed as in Fig. 3. "The percentage of receptors in internal membranes
is the amount of receptor detected in Renografin gradient fractions 1-7 divided by the total
amount of receptor assayed. Entres are the mean :t standard error for three independent
experiments.
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Internalization of Ste2- T326-GFP was also monitored by using fluorescence
microscopy. In the control cells exposed to a-factor, wild-type Ste2-GFP was depleted
from the plasma membrane (Fig. 9, top row), and all of the cells examned contained
fluorescent foci (Table 3). When expressed alone, the vast majority of Ste2- T326-GFP was
at the cell surace at all times, consistent with the endocytosis defect of ths mutat (Fig. 9,
middle row, and Table 3). However, when cells coexpressing both Ste2-T326-GFP and
untagged wild-type receptors were exposed to a-factor, plasma membrane fluorescence was
diminished and was accompaned by intracellular accumulation of fluorescent foci (Fig. 9,
bottom row, and Table 3). A signficant portion of the trncated receptor was internalzed
after addition of a-factor and appeared in punctate strctures resembling endosomes (Fig.
2, bottom row). These results are in agreement with the Renografin density gradient
experiments (Table 2) and suggest that oligomeric complexes containing
internalzation-defective trncated receptors and wild-type receptors are internalzed in an
factor-dependent fashion with high effciency.
The C-terminal cytoplasmic tail and cysteine residues of Ste2 are not required for
oligomerization
Coimmunoprecipitation experiments were used to test whether specific strctural
features of the receptor play an essential role in the formation of oligomers. To test whether
the C-termnal cytoplasmic tail of the receptor is dispensable for oligomerization, I
coexpressed two trncated forms of the receptor that were tagged differentially and
performed coimmunoprecipitation tests on the detergent-solubilized receptors as described
in Fig. 1. Coprecipitation of Ste2-326-GFP and Ste2-326-HA was observed when the
precipitating antibodies were either anti-GFP or anti-HA (Fig. 11). Ths result suggests that
factor
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Figure 9. Ligand-induced internalization of GFP-tagged endocytosis-defective receptors.
depends on the presence of wild-type receptors. Cultures were treated with cyclohexide
and a-factor as described in Fig. 3. First two columns are controls lacking a-factor; the
last two columns are a-factor-treated cells. GFP fluorescence images and Nomarski
images are indicated below each column. Top row, cells expressing Ste2-GFP only (strain
DJ1413-A). Middle row, cells expressing Ste2-T326-GFP only (strain DJ141O-A).
Bottom row , cells expressing both Ste2-T326-GFP and untagged Ste2 (strain DJ1411-A).
TABLE 3. Quantitation of fluorescent foci from cells expressing Ste2 and Ste2- T326
Ste2 forms expressed
percentage of cells
42 :t 9 9:t 5
100 71 :t 11
5 :t 3 5:t 3
5 :t 3 2:t 2
1O:t5 7:t 5
74 :t 4 36 :t 5
Ste2-GFP
Ste2-GFP
Ste2- T326-GFP
Ste2- T326-GFP
Ste2- T326-GFP and Ste2
Ste2- T326-GFP and Ste2
3 The forms of Ste2 expressed in each strain are shown on the leftmost column. Strains
used are, DJ1413-A (rows 1 2), DJ141O-A (rows 3, 4), DJ1411-A (rows 5 , 6).
b Fluorescent foci were counted from GFP images of cells treated with cycloheximide and
factor as in Fig. 3. The percentage of cells with one or more fluorescent foci (n l) and
the percentage of cells with thee or more fluorescent foci (n23) are shown in the presence
or absence of a-factor.
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Figure 10. Immunoprecipitation of mutant and wild-type receptors. Cells coexpressed
mutant and wild-type receptors. Membrane proteins extracted with n-dodecyl
D-maltoside were subjected to immunoprecipitation and then analyzed by using
immunoblotting methods. (A) Anti-GFP antibody precipitates Ste2-S184R-GFP and Ste2.
Cells coexpressing a-factor-binding defective receptors Ste2-S184R-GFP with untagged
wild-type receptors were analyzed. Anti-GFP antibody was used for precipitation and blots
were probed with antisera against the carboxy termnus of Ste2. Cells expressing Ste2 (lane
1). Cells expressing Ste2-S184R-GFP (lane 2). Cells expressing Ste2-S184R-GFP and
Ste2 (lane 3). Strains were DJ211- 3 (Ste2), DJ1405-A (Ste2-S184R-GFP) and
DJ1406-A (Ste2-S184R-GFP/Ste2). (B) Anti-HA antibody precipitates Ste2-HA and
Ste2- T326. Cells coexpressing trncated receptors Ste2- T326 with HA-tagged wild-type
receptors were analyzed. Anti-HA antibody was used for precipitation and blots were
probed with antisera against the amno termnus of Ste2. Strain expressing Ste2-HA and
Ste2-T326 was DJ1415-A (lanes 1 and 3). Strain expressing Ste2-HA was DJ1400-
(lane 2 and 4). The asterisks indicate the positions of the precipitating antibodies.
most of the C-termnal cytoplasmic tail of the receptor is not required on either parner for
oligomerization. Ths extent of precipitation was unaltered when the cells were cultured for
5 min in a-factor before analysis. The Ste2-T326 contains 29 amno acids of the N-
termnal region of the cytoplasmic tail. To rule out a possible interaction between these 
residues, a mutant receptor Ste2-8(297-391)-GFP which lacks the 94 residues from the N-
, termnal region of the tail including the 29 amino acids that were present in Ste2- T326 was
coexpressed with untagged wild-type receptors. Ste2-8(297-391)-GFP has a severe defect
in both constitutive and ligand-mediated endocytosis (see Chapter V and Fig. 12, middle
row). The mutat receptors remained on the plasma membrane in the absence and in the
presence of a-factor (Fig. 12 middle row), whereas the wild-type receptors became
completely endocytosed upon a-factor treatment (Fig. 12 top row). When cells
coexpressing Ste2-8(297-391)-GFP and wild-type receptors were exposed to a-factor, cell
surface fluorescence diminished and GFP-tagged mutant receptors appeared in endocytic
vesicles (Fig. 12 bottom row). Ths result suggests that the entire cytoplasmic tail of the
receptor is unnecessar for oligomerization.
Another consideration was whether either of the two cysteine residues in the
receptor was essential for oligomer formation. The Ca 2+ 
-sensing and metabotropic
glutaate receptors have been proposed to dimerize though disulfide bonds (Bai et aI.
1998; Romano et al. , 1996). Two differentially-tagged forms of the receptor were
coexpressed under the direction of the strong TDH3 promoter. Plasmid pNED1(-Cys)
encodes a mutant form of the receptor (Ste2-C59S , C252A-Flag-His6) that lacks both
cysteines and contains the Flag epitope, and this plasmid was introduced into strain 440-
that directs synthesis of wild-type receptors containing the T7 epitope. Ste2-C59S
C252A-Flag-His6 was precipitated with the anti- T7 antibodies (Fig. 13), indicating the
presence of oligomers even though one of the receptors lacked cysteine residues. Therefore
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Figure 11. C-termnal tail of Ste2 is not required for coprecipitation. Cells expressing
both Ste2-T326-HA and Ste2-T326-GFP (strain DJ1417-A) were treated with a-factor and
processed for immunoprecipitation as in Fig. 2B. (A) Anti-HA antibody precipitates
Ste2-T236-GFP. (B) Anti-GFP antibody precipitates Ste2-T326-HA.
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Figure 12. Ligand-induced internalization of other GFP-tagged endocytosis-defective
receptors also depends on the presence of wild-type receptors. Cultures were treated with
cycloheximide and a-factor as described in Fig. 3. The left column shows GFP
fluorescence images of controls lacking a-factor; the right column shows the
factor-treated cells. Top row, cells expressing Ste2-GFP only (strain DJ1494). Middle
row , cells expressing Ste2-8(297-391)-GFP only (strain DJ1443). Bottom row, cells
expressing both Ste2-8(297-391)-GFP and untagged Ste2 (strain DJ1445).
106 
Figure 13. The two cysteines in Ste2 are not required for coprecipitation. Cells expressing
only T7-Ste2 (lane 1) or both T7-Ste2 and Ste2-C59S, C252A-Flag-His6 (lane 2) were
processed for immunoprecipitation as in Fig. 2B. Anti-TI antibody was used for
precipitation and blots were probed with anti-FLAG antibody. Strains were DJ440-A and
DJ440-A/pNED 1.
the C-termnal cytoplasmic domain and interchain disulfide bonds are unnecessar for the
formation of receptor oligomers.
Discussion
In this chapter, I present evidence indicating that the a-factor receptors from S.
cerevisiae form oligomeric complexes in the plasma membrane. Protein complexes
containing the receptor were effciently solubilized with the non-denaturing detergent
dodecyl ~-D-maltoside, and, on glycerol density gradients, they sedimented as a
monodisperse species with a sedimentation coefficient of about 8S. When the complexes
containing differentially-tagged receptors were solubilized under these conditions and
subjected to immunoprecipitation, both tagged species were precipitated with antibodies
specific for either of the two tags. The effciency of coprecipitation was not infuenced by
the presence of a-factor in the culture prior to extraction. Membrane fractionation and
fluorescence microscopy indicated that oligomeric receptor complexes were subject to
endocytosis and that unoccupied receptors could parcipate in these complexes. First
tagged mutant receptors, that lacked the SINAKSS endocytosis signal and were unable
to undergo constitutive and ligand-induced endocytosis , became competent for endocytosis
when they were coexpressed with untagged wild-type receptors. Second, unoccupied
receptors were able to enter these endocytosis-competent complexes since tagged mutant
receptors that were unable to bind a-factor also showed ligand-dependent endocytosis when
they were coexpressed with untagged wild-type receptors. The complex formation between
these receptors was confIrmed biochemically since coimmunoprecipitation of mutat and
wild-type receptors was observed.
Q A recently-published independent study also reports evidence for oligomerization of
factor receptors (Overton, 2000 #67). These authors used fluorescence resonance energy
transfer between differentially-tagged receptors in whole cells as an indicator for
oligomerization. They also showed that tagged receptors lacking the SINNDAKSS
endocytosis signal were endocytosed when coexpressed with wild-type receptors; however
they did not explore the endocytosis of unoccupied receptors , and they did not identify
complexes in a membrane-free detergent-soluble system.
Little is known about the size and the strcture of the oligomeric complexes that
contain GPCRs. Although detergent-solubilized a-factor receptors (48 kDa) sedimented
faster than the IgG marker protein (160 kDa), the extent to which detergent, shape,
hydration and other proteins contrbute to the sedimentation rate is not known. Two
observations indicate that at least a porton of the a-factor receptor complexes contain more
than one receptor molecule. First, the HA-tagged receptors sediment slightly faster than the
GFP-tagged receptors even though the GFP-tagged receptors are larger, consistent with
reduced stability of the GFP-tagged oligomers. Second, 6-11 % coprecipitation of the
differentially tagged receptors indicates that a minimum of 12-22% of these complexes is in
oligomers (assuming two receptors per complex). Ths value is likely to be 
underestimate since some complexes may disaggregate durng analysis and since
tighter-associating forms (i. e. , Ste2-HA) may tend to reassociate into relatively stable
homo-oligomers leaving the weaker interacting species (i. e., Ste2-GFP) to form less-stable
oligomers. Based on the extensive cointernalzation of mutant and wild-type receptors, it is
liely that most of the receptors are in the oligomeric form in vivo. The strctual
determnants that bind a-factor receptors together are also unclear. Although metabotropic
glutamate and Ca -sensing receptors require the disulfide bonds of cysteines for
oligomerization and 8-opioid receptors oligomerize though sequences in the C-termnal
domain, I find that neither these strctual features play an essential role in the
oligomerization of a-factor receptors. Although transmembrane segment VI of ~2
; .
adrenergic receptors and D 1 dopamne receptors are thought to play an essential role in
aggregation, ths possibility has not yet been explored for the a-factor receptor. These data
do not exclude the possibilty that a bridging protein mediates the association of receptor
molecules.
Functional consequences of GPCR oligomerization are not well understood. The
ability of one receptor to infuenc the activity of another receptor in the same oligomeric
complex has been inferred from the cooperative binding of type-specific agonists to cells
that coexpress 8- and K-opioid receptors. Although the hypersensitivity phenotype 
trncated a-factor receptors is reversed when they are coexpressed with wild-type receptors
(Konopka et al. , 1988; Reneke et aI., 1988), ths phenomenon is most readily explained by
competition of the mutant and wild-type receptors for a common pool of G proteins (Dosil
et al. , 2000) rather than by diect aggregation of the two receptor forms. The functional
consequences of disrupting GPCR oligomerization in vivo has been investigated by
exposing cells to peptides corresponding to single transmembrane segments of the receptor.
A peptide that comprises transmembrane VI of ~2-adrenergic receptors inhJ?its both
oligomerization and signal transduction activities of these receptors
, suggesting that
oligomerization may be essential for signaling (Hebert et al., 1996). However
, the
significance of this argument has recently been called into question since
, for D1 dopamne
receptors, a peptide containing transmembrane segment VI inhbits signalng without
inhbiting oligomerization (George et aI. , 1998). It is possible that varations in the amount
of oligomerized GPCRs mediate the response to agonists since the oligomeric state of some
GPCRs is either increased or decreased by ligand binding (Cvejic and Devi
, 1997; Hebert et
aI. , 1996). For the 8-opioid receptor, the dimer-to-monomer transition has been associated
with endocytosis since the natural agonists induce monomers prior to endocytosis and since
morphine does not induce receptor internalization and does not alter the oligomeric state
(Cvejic and Devi , 1997). Disaggregation of a-factor receptors does not appear to control
ligand-mediated endocytosis since the aggregation state is unaffected by the a-factor and
since endocytosis-defective mutant receptors are internalized when they are associated with
wild-type receptors. a-factor receptors provide a genetically-tractable model to study the
role that oligomerization plays in the GPCR function.
CHAPTER IV
INTERACTIONS OF THE a-FACTOR PHEROMONE RECEPTOR WITH
OTHER PROTEINS
protein-coupled receptors rely on the action of heterotrmeric G proteins to relay
the extracellular signals to the cell interior. Receptor stimulation by the ligand results in a
GDP/GTP exchange in the a subunit of the G protein, which is thought to cause the Ga to
dissociate from the G~y heterodimer. Following activation, the Ga is thought to dissociate
from G~y and the free Ga and G~y are then available to interact with the downstream
effectors. There are four subfamlies of Ga subunits, which interact with different effectors
in mamalan cells: G activates adenylyl cyclase, whereas G inhbits adenylyl cyclase and
activates K+ channels. Gq/ll regulates phospholipase C (Ostrom et aI., 2000). Finally
'2I13 stimulates Bruton s tyrosine kinase and a rasGAP (Jiang et aI. , 1998; Naor et aI.,
2000). The G~y subunits have been shown to interact with protein serine/theonine kinase
KSR- 1 and PI3Ky. (Naor et aI. , 2000).
In yeast, only one heterotrmeric G protein couples to the pheromone receptors
(Ste2 and Ste3). The homologs of the mamalian a, ~ and y subunits of the heterotrmeric
G protein are encoded by GP Al , STE4 and STE18 genes, respectively. Another protein
homologous to Ga subunit (GPA2) which is believed to associate with another yeast
GPCR tJprl , has been implicated in pseudohyphal growth (Nakafuku et aI. , 1988; Pan and
Heitman, 1999; Xue et al. , 1998). Strains caring a deletion of the GPA2 gene have no
defects in the pheromone response pathway. For the pheromone receptors, the G~y subunit
interacts with the downstream effectors. The role of Ga is thought to be to maintan the
heterotrmer in its inactive state. Upon activation, the free G heterodimer interacts with a
scaffolding protein Ste5 that normally shuttles betwe n the nucleus and the cytoplasm. Ths
interaction causes the stable recruitment of Ste5 to the plasma membrane and brings thee
members of the mitogen-activated kinase famly, Stell , Ste7 and Fus3, bound to Ste5 in
close contact with Ste20. Phosphorylation of Stell by Ste20 initiates that kinase cascade.
When the GTP bound to Ga is hydrolyzed to GDP, Ga reassociates with the G~y
rendering the complex inactive, thereby turnng off the signal. The slow intrnsic GTPase
activity of Ga is stimulated by the action of a regulator of G protein signaling protein, Sst2
(Apanovitch et al., 1998).
In recent years, high resolution crystal strctures of all thee G protein subunits and
recently one GPCR have been solved (Lambright et al. , 1996; Palczewski K, 2000; Sondek
et al. , 1996; Wall et aI. , 1995). Whle these and other studies have provided a framework
for understanding the strcture of G-proteins and GPCRs as well as the interactions among
the G protein subunits , some basic questions regarding the receptor-G protein interactions
remain unanswered. For example, it is currently unkown how G proteins are activated and
what residues constitute the points of contact between receptors and G proteins. Ultimately,
answering these kinds of questions wil require solving the crystal structure of the extended
receptor-heterotrmeric G protein complex. So far, studies analyzing receptor-G protein
interactions mostly rely on indirect methods. Some examples include membrane binding
studies employed with in vitro- translated Ga proteins (Onrst et al. , 1997; Osawa and
Weis J 1995), measurement of signaling from receptor chimeras expressed with varous
mutants of Ga proteins (Liu et al. , 1995) and crosslinkng of receptor-derived peptides to G
proteins (Taylor et al. , 1994; Taylor et al. , 1994; Taylor et al. , 1996). In some cases,
receptor-G protein complexes have been successfully copurified (Brown and Schonbrunn,
1993; Law and Reisine, 1997; Law et al. , 1993).
So far, the studies in yeast that point to an interaction between the receptor and its
cognate G protein have been indirect. First, the affinity of the receptor for the ligand is
decreased in a ste4/J strain (Jenness et al. , 1987). Second, the dissociation rate of a-factor
is increased in the presence of GTP analogs (Blumer and Thorner, 1990). Additionally
since overexpression of the G protein subunits relieves the phenotype due to interaction
between dominant negative and wild-type receptors , it has been proposed that these
receptors compete for binding to a limiting pool of G proteins (Dosil et al., 1998; Leavitt et
al., 1999). Moreover, synthetic' lethal interactions between ste2/J and a temperature-sensitive
allele of GPAl suggest direct interaction between Ga and the receptor (Dosil et al. , 2000).
In ths report, I have used a crosslinkng- and immunoprecipitation-based approach
to captue receptor-G protein interactions in yeast. I have crosslinked the a-factor
pheromone receptor to form a higher molecular weight complex. The G subunits were
then identified in the complexes that had been immunoprecipitated with an antibody directed
against a tagged form of Ste2. These results constitute the fIrst biochemical evidence for an
interaction between the receptor and the G proteins in ths system. It is also the fIrst
biochemical interaction of Ste2 with a protein other than itself and its ligand. Ths approach
can be used as an assay to identify the critical residues required for receptor-G protein
interactions. This type of interaction wil be important for defining how G proteins are
activated.
Results
Crosslinking of receptors
A chemical crosslinkng and immunoprecipitation approach was undertaken to
identify proteins that interact with the a-factor receptor. The purpose for using protein
crosslinkng was to capture the proteins that interact transiently or weaky with Ste2 
including them in a covalently-linked complex with Ste2. Moreover, weak interactions
between the receptor and its binding proteins should be preserved durng the subsequent
processing of the samples. The goal was then to immunoprecipitate the complex with an
antibody directed against a peptide tag fused with Ste2, to cleave the crosslinker and then to
identify the contents of the complex by using either western blotting methods or mass
spectrometr. A water soluble, amne-reactive crosslinkng agent DTSSP
ditho-bis-(sulfosuccinimidylpropionate) was chosen. The advantages to using this
crosslinker are several fold. First, it contains a disulfide bond between the two functional
groups and therefore, following immunoprecipitation it can be cleaved with reducing agents
thus permtting the separation and identification of the individual crosslinked proteins.
Second, DTSSP has specificity for primar amines located on lysines or on the N termni
of proteins. This propert allows the HA epitope tag on Ste2 constrcts to escape
modification since HA is an internal epitope tag and contains no lysine residues. In
addition , since DTSSP is water-soluble, it targets cytoplasmic domains of proteins and can
be used for identification of cytoplasmic proteins interacting with Ste2. Ste2 contains 16
lysine residues most of which are found at the cytoplasmic face of the receptor makng them
candidates for modification by DTSSP (Fig. 1).
Lysates from cells expressing Ste2 tagged at the C-termnus with the trple infuenza
epitope (HA) were treated with DTSSP. The lysates were processed for SDS-PAGE under
non-reducing conditions and analyzed by western blotting. One concern was
overcrosslinkng , that is, crosslinkng unrelated cellular proteins into a few large complexes
to a point that the distrbution of the bulk protein bands on SDS gels would be lost. To test
whether 'overcrosslinkng ' had occured, I monitored the extent of crosslinkng by using
western blotting to judge the molecular weight of Ste2-contaning aggregates (Fig. 2A) and
by protein staining of the blots (Fig. 2C). The crosslinkng did not alter the overall pattern
of cellular protein bands on the SDS gels dramatically and treatment of the samples with
reducing agents, ~ME and DTT reversed the effect (Fig. 2C). When the crosslinked lysates
were analyzed by immunoblottng methods, thee slower-migrating species (complexes 1
and 3) were detected that resulted from chemical crosslinkng (Pig 2A compare lanel with
lanes 2 and 3). The molecular weights of complexes 1 and 2 could not be determned since
complex 1 barely entered the stacking gel and complex 2 barely entered the resolving gel. It
is not clear whether the complexes 1 or 2 represent single species or multiple species of
similar size. Increasing the crosslinker concentration resulted in an increase in the amount
of the two larger species (complexes 1 and 2) compared with the amounts of the two smaller
species (free Ste2 and complex 3) (Fig. 2A and 2B). Similar results were obtained when
the lysates were prepared from cells that had been treated with a-factor (Fig 2A compare
lane 6 with lanes 7 and 8) or when a-factor was added to the lysates prior to incubation with
the crosslinker (Fig. 2A lanes 4 and 5).
!, 
Complexes 2 and 3 were not disrupted by ~-mercaptoethanol or DTT, and might
represent what are called 'SDS-resistant dimers ' and tetramers of the receptor.
SDS-resistant dimers are higher molecular weight aggregates that are detected during the
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Figure 1 . Residues of interest in the a-factor receptor. The lysine residues are shown in
black. The endocytosis motif SINAKSS sequence is denoted in gray. Putative
endocytosis signal GPFAD sequence is marked with textured circles. The residue 326 is
also numbered.
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Figure 2. Crosslinkng of the a-factor receptor. (A) Cells expressing Ste2-HA were
untreated (lanes 1-5) or treated with 10- M a-factor (lanes 6-8). Lysates were prepared.
Lysates prepared from cells that had been untreated, were treated with 10- M a-factor
(lanes 4 and 5). Then alilysates were incubated for 2 hours on ice with 0, 2.5 or 5 mM
DTSSP as designated above each lane. Tota protein loaded in each lane was 1.6 ~g. The
crosslinkng reactions were quenched by adding one-fourth volume of 1M Tris-Cl (pH
7.4). The samples were processed for SDS-PAGE analysis in non-reducing sample buffer.
. Samples were resolved on a 10% SDS gel. Ste2-HA was detected by immunoblotting
meth ds with anti-HA antibody. Complexes 1 3 and free Ste2-HA are indicated on the
left, whereas the boundares of the stacking gel and molecular weight markers are indicated
on the right. (B) Cultures expressing Ste2-HA had been treated with 10- M a-factor.
Whole-celllysates were treated with DTSSP as for panel A. Protein complexes were
resolved on an 8% SDS gel and detected by immunoblotting methods with anti-Ste2
antibodies. Complexes 1 2 and 3 are marked as indicated in panel A. The samples in lanes
4 and 5 were identical to lane 3 except that they were treated with reducing agents, 100 mM
~ME or 50 mM DTT (lanes 4 and 5 , respectively) immediately prior to loading.
(C) Reversible crosslinkng of bulk cellular protein. The immunoblot that had been
processed in panel B was subsequently stained with Colloidal Gold. The Colloidal
Gold-stained blot is the mior image of the immunoblot shown in Panel B. Molecular
weight markers are shown in the right for all blots. The strain was DJ1400-
SDS-PAGE analysis of Ste2 and some other proteins with hydrophobic regions such as
glycophorin A, tailspike protein from phage P22 and some GPCRs including
~-adrenergic receptors (Blumer et al. , 1988; Furtayr and Marchesi, 1976; Hebert et aI.,
1996; Konopka et aI., 1988; Yesilaltay and Jenness, 2000). The molecular weight and
doublet migration pattern of complex 3 are consistent with receptor dimers. Similar dimer
complexes have been observed upon treatment of other GPCRs, such as ~-adrenergic and
8-opioid receptors, with membrane permeant crosslinkng reagents; however, the authors did
not report whether these SDS-resistant dimers are cleaved under reducing conditions
(Cvejic and Devi, 1997; Hebert et al., 1996). In my experience, the SDS-resistant species
were not cleaved completely under reducing conditions (Fig. 2B and data not shown). They
were detected even in the absence of the crosslinker, and their occurrence and proportion
vared among different preparations. Therefore they were not studied furter.
According to thee criteria, complex 1 represents a crosslinker-specific, covalent
association of the receptor with itself or with other proteins: (i) it was formed only upon
addition of the crosslinker, (ii) the crosslinker caused a dosage-dependent increase in the
ratio of complex 1 to free receptor, and (iii) complex 1 disappeared upon cleaving the
crosslinker with reducing agents DTT (fig. 2B , lane 4) and ~ME (lane 5). The complexes
were not formed as a result of association of proteins with the HA tag since the HA epitope
does not contain lysine residues or an a amno group.
Lysates were prepared from cells that cared single or multiple deletions in the
genes encoding the components of the signal transduction cascade downstream of the
receptor. Lysates were then treated with DTSSP and analyzed by western blotting methods.
The purose was to find out if a complex of small size would form in the absence of the
proteins that may link the receptor to the rest of the complex. A reduction in the size of the
complex would suggest that the missing component was par of the original complex, and
would simplify the identification of other proteins that remained in the small complex.
However, similar size complexes were detected upon crosslinkng and western blotting
analysis of strains that harbored individual deletions in STE4 , STE5 and SST2 genes and
double deletions in GPAl and STE5 or in AKRl and STE5 genes or triple deletions in
AKR1 , STE5 and GPAl genes (not shown). A trncated version of the receptor
Ste2- T326- , that lacks most of the carboxy termnal tail and has only about half the
number oflysines on the cytoplasmic surface (see Fig. 1), also formed a complex that was
comparable in size to complex 1 (not shown).
Identifcation of G~y heterodimer in the complex
The next goal was to test whether any subunits of the heterotrmeric G protein were a par of
the complexes containing receptor. Crude membranes were prepared from crosslinked
lysates of cells expressing Ste2-HA. Membrane proteins were extracted by the relatively
non-denaturing detergent n-dodecyl ~-D-maltoside (D~M), and the complexes were
immunoprecipitated by using anti-HA antibodies. All three high molecular weight
complexes that were previously detected (Fig. 2A) were present in the IP pellet (data not
shown). The precipitated proteins were exposed to reducing agents, resolved by
SDS-PAGE and analyzed by immunoblotting methods. To evaluate the presence ofG
proteins in the complex, I probed the blots with antisera specific for Ste4. Ste4 was found
to coimmunoprecipitate with Ste2-HA only after the lysates were crosslinked (Fig. 3A top
panel compare lanes 3 and 4). The coprecipitation of Ste4 depended on the presence of the
HA-tagged Ste2, because it was absent in the immunoprecipitates obtained from control
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Figure 3 . G~ subunit is crosslinked to and coprecipitates with the a-factor receptor. Cell
lysates were treated with 5mM DTSSP as in Fig. 2 except protein to crosslinker
concentration was approximately ten times higher. Ste2-HA in the detergent-solubilzed
membrane fraction was precipitated with anti-HA antibodies. The precipitated proteins were
processed for SDS-PAGE with sample buffer containing reducing agent. Imunoblots
were probed with anti-Ste4 antibody (upper blots in each panel) or anti-HA antibody (lower
blots in each panel). The asterisks indicate the position of the immunoglobulin heavy
chains. (A) Cells expressed untagged Ste2 (lanes 1 and 2) or Ste2-HA (lanes 3 and 4).
Cells were untreated (lanes and 3) or treated with 5 mM DTSSP (lanes 2 and 4). (B) Cells
expressed untagged Ste2 (lanes land 4) or Ste2-HA (lanes 2, 3, 5 and 6). Strain used in
lanes 3 and 6 also harbored a deletion of the STE4 gene. D~M (lanes 1-3) or SDS (lanes
6) was used to extract proteins from the membrane pellet. Strains were DJ211- 3 (Ste2),
DJ1400-A (Ste2-HA) and DJ1495 (Ste2- , ste48).
cells expressing untagged Ste2 (Fig. 3A top panel, compare lanes 2 and 4). The band was
positively identified as Ste4 since it was missing when experients were repeated with
ste4/J cells. (Fig. 3B top panel, compare lanes 2 and 3). Ste4 appeared to be associated with
the complex, because it also coprecipitated with Ste2-HA under denatung conditions
(Fig. 3B top panel , compare lanes 2 and 5).
Ste4 is known to become phosphorylated upon prolonged exposure to a-factor (Cole and
Reed, 1991). The phosphorylated Ste4 migrates more slowly on SDS-PAGE.
Coprecipitation of both the phosphorylated and the unphosphorylated forms of Ste4 was
observed when the crosslinkng and precipitation experiments were performed with cells
that had been exposed to a-factor (Fig. 4, second row). In vivo, Ste4 and Ste18 form a
heterodimer. As expected, Ste18 was also detected in the precipitates (Fig. 4, thd row).
The interaction detected was not the result of nonspecific crosslinkng as suggested by the
absence of other more abundant cytoplasmic or membrane proteins in the pellet, including
the ribosomal protein, Tcm1 , and abundant plasma membrane ATPase Pma1 , respectively.
These data suggest that the receptor and G~ form a complex in vivo and provide the fIrst
biochemical evidence for a physical association of receptor and G proteins in ths system.
In addition , these results provide a biochemical tool to analyze these complexes fuer. 
mamalan systems, a direct interaction between a2-adrenergic receptors and the G~
subunit of the GJG protein famly has been proposed based on binding studies with a
receptor-derived peptide to G~ (Taylor et al. , 1994; Taylor et al. , 1994). We canot
however, exclude the possibilty that the association we observe results from indiect
interactions, that is , though a bridging protein between the receptor and Ste4.
The C-termnal tail of the a-factor receptor has been proposed to stabilize the
interactions with the G protein (Dosil et al. , 2000). I sought to determne whether a
trncated version of the receptor, Ste2- T326-HA lacking most of the tail would form a
complex with Ste4. Cells expressing Ste2- T326 are unable to endocytose their receptors
but are proficient for signaling (Rohrer et aI. , 1993; Schandel and Jenness, 1994), Initial
crosslinkng analyses indicated that Ste2- T326-HA formed a reversible high molecular
weight complex upon treatment with DTSSP (not shown). Subsequent crosslinkng and
coimmunoprecipitation experiments revealed that 10% of Ste4 was coprecipitated with the
trncated receptor (Fig. 5), whereas about 1 % of Ste4 was coprecipitated with the wild-type
receptor typically. Ths difference may reflect the 3- to 4-fold higher accumulation of the
trncated receptors at the cell surace. Higher levels of Ste4 were also found to
coprecipitate when wild-type Ste2 was overexpressed (not shown).
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Figure 4. Both G~ and Gy crosslink to and coprecipitate with the a-factor receptor.
Strains expressed untagged Ste2 (lanes 1, 5 and 6) or Ste2-HA (lanes 3, 4, 7 and 8).
Cultures were untreated (lanes 1 5 and 7) or treated with 10- M a-factor for 30 min
(lanes 2, 4, 6 and 8). Celllysates were treated with 5 mM DTSSP as in Fig. 3. The
DBM-solubilzed membrane fraction was subjected to immunoprecipitation with anti-
antibodies. The input membrane fraction (lanes 1-4) and precipitated proteins from the
immune pellets (lanes 5-8) were processed for SDS-PAGE in sample buffer under reducing
conditions. Samples were analyzed by western blotting on three geJs. The blots labeled
Ste2 and Ste4 were obtained from 10% SDS gels and were reprobed with anti-Pma1 and
anti-Tcm1 antibodies, respectively. The blot probed with anti-Ste18 was obtained from an
18% SDS gel. Immune blots were probed with anti-Ste2 antibody specific for Ste2
termnal domain (top panel), anti-Ste4 (second row), anti-Ste18 (thd row), anti-Pma1
(fourth row) or anti-Tcm1 (fifth row) antibodies as indicated on the left. Strains were
211- 3 (Ste2) and DJ1400-A (Ste2-HA).
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Figure 5. 10% of the G~ subunit from the membrane fraction coprecipitates with the
trncated a-factor receptor. Lysates were prepared from cells expressing ste2- T326-
(Strain DJ1416-A). Crosslinkng and precipitation experiments with the anti-HA antibody
were cared out as described in Fig. 4. The whole cell membranes (lanes 1-4) and
precipitated proteins from the immune pellets (lane 5) were processed for SDS-P AGE in
sample buffer under reducing conditions. Percent loading for each sample is indicated
above each lane.
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Search for other proteins in the complex
An attempt was made to identify new proteins that associate with the a-factor
receptor. To this end, lysates were prepared from a strain that cared a plasmid that results
in the overproduction of a mutant form of Ste2 (designated HA-Ste2-Ff-HT).
HA-Ste2-Ff-HT lacks the two cysteines and contains an HA epitope on the N-termnus and
both a FLAG and His6 epitopes on the C-termnus. The two cysteine residues in Ste2 do
not seem to be required for receptor function since a receptor mutant that lacks both
cysteines shows no detectable defect in plasma membrane localzation, signaling (Jeremy
Thorner personal communication) or oligomerization (Yesilaltay and Jenness, 2000). The
lysates were incubated with DTSSP and centrfuged at 100,000 x g. Then the receptor
complexes in the pellet were extracted with the non-denaturing detergent, D~M
immunoprecipitated with anti-HA antibody, and were purfied further by using a Nickel
column under protein denaturing conditions. The samples were eluted from the column by
using SDS sample buffer, and the eluate was subjected to both SDS-PAGE and 2D gel
electrophoresis under reducing conditions, and the proteins on the gels were detected with
silver staining. As a preliminar experiment, I identified four prominent bands on
one-dimensional SDS-PAGE gels. These bands were putative Ste2-interacting proteins
based on the following criteria: fIrst they were purified only in the presence of the tagged
receptor e., they were missing from the immunoprecipitates obtained from control cells
expressing untagged Ste2 (Fig. 6 compare lanes 1 and 2). Second, these proteins were not
derived from the N-termnal or the C-termnal domain of Ste2 since, when the same samples
wer analyzed by using western blotting methods, the bands did not overlap with the signal
that was obtained with anti-FLAG antibodies, anti-HA antibodies and anti-Ste2 antibodies
specific for N- and C-termni of the receptor (not shown).
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Figure 6. Detection of the putative Ste2-interacting proteins. Lysates from cells lacking
(lane 1) or caring the plasmid expressing HA-Ste2-FT-HT (lane 2) were subjected to
crosslinkng and precipitation with anti-HA antibodies as described in Fig. 3. The
precipitated material was then solubilzed and bound to a Ni-column. The eluate from the
column was processed for SDS-PAGE analysis in sample buffer under reducing
conditions. The proteins on the gel were detected with silver staining (left panel). The
immunoblot was probed with anti-HA antibodies (right panel). The arows mark the two
putative Ste2-interacting proteins p34 (the upper arow) and p32 (the lower arow). The
.,'
single and double asterisks mark the immunoglobulin light and heavy chains, respectively.
Strains were DJ1448 (ste28) and DJ1449 (HA-Ste2-FT-HT).
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Figure 7. Two-dimensional electrophoretic detection of putative Ste2-interacting proteins.
Lysates prepared from cells (A) lacking (strain DJ1448) or (B) caring the plasmid that
expresses the HA-Ste2-Ff-HT (strain DJ1449) were processed for crosslinkng, and then
for immunoprecipitation with anti-HA antibodies. The proteins in the eluate were fIrst
incubated in a reducing sample buffer and then were resolved by 2D gel electrophoresis.
Thck arows in panel B point to spots that indicate putative Ste2-interactoing proteins.
Thin arows indicate thee groups of spots with a similar migration pattern in SDS-PAGE.
The difference in isoelectrc focusing points may reflect Ste2 species whose charges were
altered during sample preparation (e.g. due to deamdation of glutane or asparagine
residues , or due to modification of lysine residues by the crosslinkng reagent). The top
two corners of the gels were cut to mark the length of the isoelectric focusing strp. The
brackets show the position of the immunoglobulin light chain. The brackets show the
position of the immunoglobulin heavy chain. The molecular weight markers are shown on
the right. The positions of the molecular weight markers were estimated according to the
relative positions of the immunoglobulin heavy and light chains.
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shown). Several putative interacting proteins were detected on the 2D gel analysis of the
strain expressing the tagged Ste2 (Fig. 7B , arows) that were not observed on the negative
control gel (Fig. 7 A). As expected, the immunoglobulin heavy and light chains were present
in both gels (Fig. 7 A and Fig. 7B). Three groups of spots (Fig. 7B , thin arows) that had
similar molecular weights were resolved along the isoelectrc focusing dimension. These
may represent Ste2 species whose charges were modified by the crosslinker or by the other
modifications (e. phosphorylation or deamdation). Ste2 typically migrates as a doublet
on SDS-PAGE gels due to single and double glycosylation events that occur on its
termnus. The receptor species that resolve in the second dimension may represent the
glycosylated forms of Ste2. The putative Ste2 species are positioned between pH 5 and 6
with the darkest one approximately at pH 6. Using EMBOSS IEP program (Rice et al.
2000), the isoelectrc point of Ste2 was calculated to be 6. 15. Ths value suggests that the
darkest groups of spots are unmodified Ste2 species. In addition, the same software was
used to calculate the pI of Ste2 when a few lysines are changed to alannes in order to mimic
the loss of positive charge on the protein when lysine residues are modified by the
crosslinker. The following pI values were obtaned for Ste2 with one, two and three lysine
changes: 5.75, 5.40 and 5. , respectively. The positions of the two additional putative Ste2
species indicate that their pI values are in agreement with these values, and therefore, they
may represent Ste2 species that contain one or two modified lysines. In addition, the
putative Ste2 spots have similar molecular weights compared to the immunoglobulin heavy
chain spots (marked with braces) on the 2D gel. Therefore, the molecular weight, the
migration pattern and the isoelectrc points of these spots are consistent with these spots
being unmodified and crosslinker-modified Ste2 species.
The next step was to prepare greater quantities of these putative interacting proteins
and to analyze them by using mass spectrometr. The 2D analysis did not reveal many
. ,
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more bands than the single dimension. Furthermore, it was not practical to analyze more
material on the 2D method due to the limited capacity of the strps used for the isoelectrc
focusing step. Therefore, lysates were prepared from ten-fold more material and analyzed
by using one-dimensional SDS-PAGE as in Fig. 6. Proteins were detected with silver
staining methods. Two bands with molecular weights around 30 kD were cut out of the gel
subjected to in-gel trpsin digestion and analyzed by using mass spectrometr. The two
proteins possessed a few digestion products with similar molecular mass (approximately
1640, 1995 2707 and 2936 daltons, compare Fig. 8A and Fig. 8B) and therefore may have
originated from the same protein. To rule out the possibilty that the common products
were cleavage products of trpsin itself, the mass spectrometr data of the two putative
proteins were compared with data obtaned from a trpsin-only experiment. Results
indicated that only a few of the trptic fragments obtained from the two bands appeared to
be derived from trptic self-cleavage (Fig. 8, asterisks in panels A and B). However, the
molecular masses of the resulting trptic digestion products did not match cleavage
products predicted for any protein in the yeast or any other protein database. A computer
program (Sherpa Light) was used to estimate the molecular weights of the parial and
complete trypsin digestion products of Ste2. These computer-simulated trpsin digestion
products were compared with the empircal data to test whether the fragments were
degradation products of Ste2. I also considered the possibilty that some peptides may
contain the residue of the crosslinkng reagent attached to an uncleaved lysine residue. The
mass spectrometr data from the two bands did not match the predicted Ste2 fragments.
Crosslinker-modified lysines are no longer substrates for trpsin digestion. A high
protein-to-crosslinker concentration was picked to minimize modification of multiple
lysines on a given protein. However, it is possible that the proteins were modified more
severely than predicted. In ths case, it may not be possible to identify novel proteins from
the database because the complexity of the predicted peptides would be too high.
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Figure 8. The mass spectrometric analysis of the trptic digestion products of putative
Ste2-interacting proteins suggests that they are derived from the same protein. The mass
spectrometrc analysis of the (A) p34, (B) p32 (C) trpsin. Arows in panels A and B
indicate cleavage products. Asterisks indicate possible trptic cleavage products in panels A
and B. The strain was DJ1449.
108
Discussion
-- 
Ths chapter describes a crosslinkng and immunoprecipitation strategy to capture
and characterize the transient complexes that contain the a-factor receptor Ste2. Tagged
receptors were crosslinked to form at least three high molecular weight complexes and the
complexes were immunoprecipitated with antibodies agaist the tag. Western blotting
analysis of the precipitated material revealed the presence of the ~ and y subunits of the
JI:
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heterotrmeric Gprotein, Ste4 and Ste18. The interaction was specific as judged by the
absence of two abundant proteins (plasma membrane ATPase Pma1 and a ribosomal
subunit Tcm1) in the precipitate. Similar results were obtaned when the cultues had been
treated with a-factor prior to analysis. A trncated receptor missing most of the
cytoplasmic C-termnal tal was also active in binding Ste4. Overall, these results constitute
the fIrst biochemical evidence for a physical association between the a-factor receptor and
its cognate G-protein. An attempt was made to identify other components of the
crosslinked complex. A number of putative Ste2-interacting proteins were detected when
the crosslinked complexes were resolved by 1D and 2D-electrophoresis. Mass
spectrometrc analysis of trptic fragments obtained from two of these proteins suggested
that they originated from the same protein; however, it failed to identify a match in the yeast
protein database as well as in other protein databases.
One factor that might provide efficiency and specificity in transmitting the signal is
the precoupling of the G-protein-coupled receptors with their cognate G protein before
exposure to ligand (Neubig, 1994; Shea and Linderman, 1997). The issue of specificity
may be critical in mamalian systems since several different G proteins are available to
interact with receptors (Insel et al., 1983; Miligan, 1996; Ransnas and Insel, 1988). Ths
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point was previously overlooked for the most par because of the recognized promiscuity in
receptor interactions with multiple G proteins (Brown and Schonbrunn, 1993; Miligan
1996; Neubig, 1994). Early transfection studies in mamalian cells usually employed
high- level expression of the components of the system. Thus , the issue of specific
receptor-G protein coupling was avoided. Selective receptor interactions with specific G
protein subtypes have only recently been appreciated. The light-sensing receptor rhodopsin
associates much more effciently with at, transducin than with other Ga subunits present 
the retina (Cerione et al., 1985; Kisselev and Gautam, 1993). Antisense RNA directed
against the mRA encoding the G 1a subunit inhbited the activity from m4 muscarnic
receptors in GH3 cells, whereas in the same cells specific disruption of somatostatin
receptor activity has been achieved with antisense RNA that inhbits the mRA for the
2a subtype (Kleuss et al., 1991). These results suggest that GPCRs selectively bind
specific G protein subtypes from the cytoplasmic pool. Pre activation complexes would be
one mechansm to achieve the specificity of receptor-G protein interactions. Engagement of
8-opioid and somatostatin receptors with a select number of Ga and G~ subtypes in
preactivation complexes has been confIrmed by using coprecipitation studies (Law and
Reisine, 1997; Law et al., 1993). In addition in vitro- translated transducin interacts with
rod-outer segment membranes contaning rhodopsin both in the dark and in the light
(Onrst et al. , 1997; Osawa and Weiss, 1995). For all thee receptors , activation by ligand
enhanced the levels ofreceptor-G protein interactions detected in each assay.
Indirect genetic and biochemical evidence implies the existence of preactivation
comP1.rxes in yeast. The basal levels of signaling is increased in cells deleted for
pheromone receptors when reporter assays were performed using a pheromone-inducible
promoter (Boone et al. , 1993; Hasson et al., 1994) suggesting that wild-type receptors
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sequester the G proteins prior to ligand occupancy. Similarly, for cells producing a
constitutively active receptor, the basal signalng is decreased when wild-type receptors are
coexpressed (Dosil et al. , 2000). Finally, a mutation afecting Gpa1 causes lethality at high
temperature in ste2L1 cells but not in cells expressing full-length receptors (Dosil et al.
2000). However, to date no biochemical data have been available to support ths notion in
yeast. As presented in this thesis, the ability to capture the interaction between Ste2 and
Ste4 in the absence of a-factor suggests that receptor and G proteins are precoupled prior
to stimulation by ligand and therefore lends support to the existence of preactivation
complexes in yeast. Furtermore, a-factor had little effect on the Ste4 that coprecipitated
with receptors. The slight increase in coprecipitated Ste4 observed with a-factor-treated
cultures is consistent with higher level of Ste2 present in a-factor-treated cultures.
Similarly enhanced levels of Ste4 coprecipitation were observed when an overproduced
version of Ste2 was used in for crosslinkng and immunoprecipitation (not shown).
Moreover, more Ste4 coprecipitated with Ste2-T326; ths trncated receptor results in a 4-
fold accumulation of receptors on the plasma membrane due to its defect in endocytosis
(Konopka et aI., 1988).
Dosil and coworkers reported genetic findings that indicate a role for the
cytoplasmic C-termnal tail of the receptor in stabilizing the receptor-G protein interactions
(Dosil et aI. , 2000). Mutant receptors that canot bind a-factor are thought to have a
dominant negative infuence on signaling because they sequester G proteins in preactivation
complexes. However, these dominant negative receptors lose the abilty to interfere with
sign ing from wild-type receptors when they are trncated. In addition, unoccupied
full-length receptors interfere with basal levels of signaling from constitutively active
receptors, whereas trncated receptors are unable to do so. Finally, the lethality associated
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with a temperature-sensitive mutant of Gpa1 in ste2/J background is reversed upon
expression of full-length but not trncated receptors. Each of these examples is consistent
with the C-termnal tail playing a central role in sequestering G proteins. However
crosslinkng and coprecipitation studies presented in this chapter indicate that Ste2- T326 is
able to interact with both Ste4 and Ste18. Ths apparent inconsistency might be due to the
differences in the nature of the two assays. Genetic evidence indicates that the tal improves
the abilty of receptors to compete for a limiting pool of G proteins. Crosslinkng results
indicate that tail is not required for interaction in the absence of competition. In fact, it is not
surprising to detect a physical interaction between the receptor and the G proteins since the
trncated receptor is still proficient for signalng and therefore maintains its abilty to
interact with the downstream components of the signal transduction pathway. It is also
plausible that the residues responsible for the interaction between Ste2- T326 and Ste4
detected in the crosslinkng assay are different from those responsible for the interactions
detected with the wild-type receptor and G proteins. The stabilzing effect imposed by the
. C-termnal tal might introduce some contacts that do not involve proxiallysines and
therefore canot be detected with the crosslinkng reagent. Therefore, the in vitro results
presented in this thesis complement the in vivo data obtaned by Dasil and coworkers, and
further suggest the existence of a preactivation complexes in yeast.
The a subunit, Gpa1 was not detected in the immune blots of the precipitated
material. It should be noted that failure to detect crosslinkng between two proteins in ths
assay does not mean the proteins do not associate with each other. Since the crosslinkng
reagent requires two amne groups positioned withn 12A to form a covalent bond
"'-.'
effciently, the inability to crosslink only indicates that the two proteins lack two lysines in
close proximity. Additional experiments where both Ste2 and Gpa1 were tagged and
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overproduced, showed that only a small fraction of Gpa1 coimmunoprecipitates with the
receptor, and the presence of crosslinker did not interfere with or enhance the levels of
precipitated Gpa1 (not shown).
Only a small fraction (about 1 %) of Ste4 from the pariculate fraction crosslinked to
and precipitated with the HA-tagged receptor. Several factors may contrbute to ths low
level of coprecipitation. First, the concentration of the crosslinkng reagent and the
protein:crosslinker ratio were determned so as to avoid extensive non specific crosslinkng.
Consequently, some of receptors and G proteins remained uncrosslinked. Second, the
subcellular fractionation studies conducted in yeast have shown that less than half of Ste4
actually colocalizes with Ste2 on the plasma membrane (Hischman et al. , 1997). Authors
of the study reported that roughly 40% of Ste4 was found in the plasma membrane fraction
30% in other buoyant membranes and 30 % in denser fractions with no detectable
membrane markers. The pariculate fraction used in my experiments to collect the
crosslinked material prior to imunoprecipitation, was reported to contain about 85% of the
cellular Ste4 (Hischman et al. , 1997) suggesting that Ste4 from all thee distinct locations
was present in ths fraction. Thd, even though I was able to precipitate the majority of the
crosslinked material, a small fraction of the complexes stayed in the supernatant. The HA
tag was chosen since it lacks lysine residues and therefore minimizes the risk of modifying
the epitope with the crosslinkng reagent. It is possible that in some cases, the epitope tag is
buried inside the complex and therefore is unavailable to the antibody in the precipitation
reaction. Finally, the stoichiometr of the G protein:receptor has not been determned in
yeast. In mamalian systems some quantitative estimates range from 1 0-to- 1 00 fold excess
of G protein over receptors (lnsel et al., 1983; Ransnas and Insel, 1988). If there are more
G proteins than receptors in yeast, ths would readily explain why so little Ste4 would
precipitate in the assay. It would also be consistent with the observation that more G
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proteins are coprecipitated when receptors are overproduced. Ths hypothesis is in apparent
contrast with the genetic data obtained from allelic interactions between mutat and
wild-type receptors. Coexpression of signaling-defective dominant negative receptors with
wild-type receptors inhibited signaling from these receptors, and overproduction of G
protein subunits reversed ths phenotype. (Dosil et al., 1998; Leavitt et al., 1999). If an
excess of G proteins existed in yeast, such a titration effect might be hard to accomplish.
Ths observation suggests that the G protein levels become limting when receptor levels are
increased about only two-fold, assuming that both mutant and wild-type receptors were
produced in physiological levels. However, as mentioned previously not all of the G
proteins reside in the plasma membrane (Hischman et al. , 1997). In addition, the fraction
of G proteins located on the plasma membrane may not be active for coupling to the
receptor.
It is not clear whether the G~ or the Gy makes direct contact with the receptor in the
crossling assay. The data do not exclude the possibilty that the interaction detected may
be mediated by a bridging protein. As mentioned, when both the a subunit, Gpa1 , and Ste2
were overproduced, a small fraction of Gpa1 coprecipitated with the receptor, and the
coprecipitation was not dependent on the presence of the crosslinkng reagent (not shown).
Evidence from mamalian systems indicates a direct association between GPCRs and all
thee subunits of the heterotrmeric G proteins (Downes and Gautam, 1999; Miligan, 1996;
Neubig, 1994). In addition, the crystal strcture of rhodopsin reveals sufficient cytoplasmic
surace area available for interaction with all G protein subunits (Bourne and Meng, 2000;
Palczewski K, 2000). Therefore, it is plausible that all thee G protein subunits interact with
the receptor. Furter experiments are needed to map the regions of contact between the
receptor and the G protein.
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Failure to identify other Ste2-interacting proteins can be attrbuted to the interference
of the crosslinker with trpsin digestion and the production of parially digested products
that cared a piece of the covalently attached cross linker. The fIrst immunoprecipitation
protocol used the N-termnal HA tag and thereby eliminated the C-termnal degradation
products. The use of Ni-column required the His6 tag at the C termnus of the protein and
thus eliminated N-termnal degradation products. It is also possible that the crosslinker was
not able to effectively introduce covalent bonds due to the constrained arangement 
receptor domains and lack of proximallysines. The SDS-resistant dimers and perhaps
tetramers of the receptor that were ireversible by the reducing agents may have made up the
majority of complex 1.
In this chapter, I sought to identify new proteins interacting with the a-factor
receptor. I have identified Ste4 and Ste18 in the crosslinked and precipitated complexes that
"i!
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contained Ste2. These results provide the fIrst biochemical evidence for a physical
association between Ste2 and Ste4/Ste18 in ths system. In addition, my results provide
biochemical evidence for the existence of preactivation complexes in yeast and complement
the in vivo genetic studies.
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CHAPTER V
INTERNALIZATION OF THE a-FACTOR PHEROMONE RECEPTOR
Peptide motifs mediate the endocytosis of cell-surface receptors by linkng the
protein to the internalization machinery in the cell. In mamalian cells, well-defined
internalization signals include dileucine, dilysine or aromatic ring-containing motifs
(containing tyrosine or phenylalanine) (D'Hondt et al. , 2000). Two endocytic targeting
motifs have been identified in yeast. One is NPFXD , which is present in Kex2 , a resident
Golgi enzyme, and in Ste3, the a-factor receptor (Tan et aI., 1996). The other endocytic
motif DAKSS (more specifically SINNDAKSS for Ste2), was identified in Ste2 , the
factor receptor (Rohrer et al. , 1993). Two additional yeast proteins, ABC transporter
Ste6, and general amino acid permease, Gap 1 have been proposed to contain
DAKSS-like motifs that govern their endocytosis as well (Hein and Andre, 1997; Kollng
and Hollenberg, 1994). Both of NPFXD and SINNAKSS provide endocytic activity
and subsequent vacuolar degradation of truncated versions of Ste3 and Ste2 , respectively,
in that they are sufficient for endocytosis of trncated Ste2 mutants that would otherwise
lack endocytic activity (Rohrer et aI. , 1993; Tan et aI., 1996). However, in the context of
the full-length receptors, mutations affecting these signals lead to only marginal defects
in internalization suggesting that Ste2 and Ste3 contain multiple endocytosis signals (Tan
et aI. , 1996; Terrell et aI., 1998).
..,,
The mechanism by which the NPFXD sequence mediates endocytosis is not
known. In mamalian cells, analyses of aromatic ring-containing motifs were found to
-J,
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associate with the AP2 adaptor complex (Backer et aI. , 1992; Bansal and Gierasch , 1991;
Collawn et aI. , 1990; Eberle et aI. , 1991). AP2 is a component of the clathrn coat that
mediates endocytic uptake at the plasma membrane (Beltzer and Spiess , 1991; Chang et
aI. , 1993; Glickman et aI. , 1989; Nesterov et aI. , 1995; Ohno et aI. , 1995). Eps15 , an
AP2-interacting protein , was shown to bind the NPF sequence (Haffner et aI. , 1997).
Three yeast proteins End3 (Benedetti et aI. , 1994; Raths et aI. , 1993), Pan1 (Tang et aI.,
1997; Wendland et aI. , 1996) and Ede1 (Gagny et aI. , 2000), which have been implicated
in endocytosis, contain Eps15 homology (EH) domains. However, the role of adaptin
homologs and clathrn in directing endocytic processes in yeast is unclear.
The lysine and serines in the SINAKSS motif have been shown to be critical
for the endocytosis of a truncated form of Ste2 (Hicke and Riezman, 1996; Rohrer et aI.,
1993). Further analysis revealed that lysine 337 was ubiquitinated (Hicke and Riezman
1996) and that phosphorylation of all three serines is required for ubiquitination of this
lysine (Hicke et al. , 1998). Ste2 is mostly mono- and diubiquitinated , and it is degraded
in the vacuole (Hicke and Riezman, 1996; Schandel and Jenness, 1994; Terrell et aI.
1998). Apparently, short ubiquitin chains mediate endocytosis of Ste2 rather than its
degradation by the proteasome (Hicke and Riezman, 1996; Terrell et aI. , 1998).
Ubiquitin is thought to be sufficient for endocytosis (Shih et aI. , 2000), since a genetic
fusion constrct that results in covalent attachment of a single ubiquitin moiety to the
termnus of a tail-less receptor (lacking all endocytic signals) permts the fusion protein
to be endocytosed (Terrell et aI. , 1998). Mutations affecting the SINNDAKSS sequence
in the context of the full-length receptor have little effect on receptor endocytosis,
presumably because the receptor tail contains multiple lysines that serve as redundant
sites for ubiquitination. Changing all of the lysines in the receptor tail to arginines has
, ,
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been found to reduce the internalization by six-fold but does not completely abolish
receptor endocytosis (Terrell et aI., 1998). Mutations affecting any of the three serines in
the SINNDAKSS sequence in Ste2- T345 lead to loss of constitutive as well as ligand-
mediated endocytosis. In contrast, the same mutations cause only a three-fold decrease in
the rate of constitutive endocytosis in the context of the full-length receptor. It has
therefore been proposed that other signals in the tail mediate receptor uptake and operate
by a different mechanism (Terrell et aI., 1998). One candidate signal in the Ste2 tail is
the GPF AD sequence in the Ste2 tail since it resembles the NPFXD motif from Kex2 and
Ste3 (Tan et aI. , 1996).
In this chapter, I summarze my genetic analysis of endocytic signals in the
termnal tail of the a-factor receptor. Internal deletions of the STE2 gene were
constructed that remove sequences encoding selected regions of the C-termnal tail.
Strains containing these alleles were then assayed for endocytosis in the presence and
absence of a-factor. Residues from 360 to 431 were suffcient to mediate both
constitutive and ligand-mediated endocytosis of the receptor even though 63 residues
including the SINNDAKSS motif had been removed. These results suggest the presence
of at least one alternative region in the tail that mediates endocytosis of the receptor.
Another receptor mutant that only contained residues from 391 to 431 from the
termnal tail was unable to undergo constitutive endocytosis as well as ligand-mediated
endocytosis , suggesting that residues 360 to 391 are critical for endocytosis of the
Ste2-8(297-360) receptor or they may be required for function of GPFAD. Further
analysis indicated that Ste2-8(297-391) mutant did not undergo the a-factor-induced
mobilty shift characteristic of receptor hyperphosphorylation. Overall, these results
suggest that a new region in the C-termnal of the a-factor receptor is sufficient to
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mediate the constitutive endocytosis as well as the ligand-mediated endocytosis of the
receptor.
.."
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Results
Internal deletions of the a-factor receptor tail
The C-termnal tail of the a-factor receptor is thought to contain multiple
endocytosis signals , since the deletion of the well-characterized SINNDAKSS sequence
alone has little effect on endocytosis. I sought to identify additional regions in the tail
that mediate endocytosis. I used internal deletions of the STE2 that remove portions of
the tail including the SINDAKSS sequence, and I tested these constructs for
endocytosis in the presence and in the absence of a-factor. One problem in studying the
down regulation of deletion constructs is that the remaining portions of the tail may
become more susceptible to cellular proteases and may be degraded leaving a tail-less
receptor that is proficient in binding the a-factor but is unable to undergo endocytosis.
Consequently, the binding assays performed with strains harboring deletion constructs
may be simply measuring binding to tail-less receptors (Konopka et aI. , 1988). In order
to circumvent this potential problem , GFP was fused after the C-termnal residue of each
construct. Therefore, detection of GFP ensures that the rest of the tail is intact. GFP did
not alter the function of the receptor as evidenced from halo assays and down regulation
assays. The C-termnal cytoplasmic domain of the receptor extends from residue 297
through the C-termnus at residue 431. Constructs that encode receptors with specific
defects in the C-termnal tail are depicted in Fig. 1. These receptor-GFP fusions under
the control of the native STE2 promoter were integrated into the chromosomal URA3
locus f a ste2/J strain. The ability of these fusion proteins to und rgo endocytosis was
evaluated by fluorescence microscopy.
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Figure 1. The schematic representation of the C-termnal cytoplasmic tails of varous
factor receptor-GFP fusion constrcts. The positions of the lysine-to-arginine
mutations are indicated as cross signs. The positions of SINNDAKSS an GPFAD
sequences are shown for the wild-type construct.
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I analyzed strains caring deletion mutants of Ste2 tagged with. GFP. Cells had been
treated with cycloheximide to block new protein synthesis. The microscopic analysis of
strains caring GFP-tagged wild-type receptors typically revealed fluorescence on the
cell surface and in the vacuole in the absence of a-factor (Fig. 2 , top row , left panels).
When the cells were treated with a-factor, the wild-type receptors were rapidly
internalized and transported to the vacuole for degradation. As a result, the cell-surface
fluorescence diminished (Fig. 2, top row, right panels). Cells expressing
Ste2-8(297-360)-GFP were subject to endocytosis upon a-factor treatment as evidenced
by a reduction in cell surface fluorescence (Fig. 2, middle row). Cells producing
Ste2-8(297-391)-GFP did not endocytose their receptors since their cell surface
fluorescence did not diminish following a-factor treatment (Fig. 2, bottom row). It also
appeared that Ste2-8(297-360)-GFP was internalized more slowly than the wild-type
receptors, since a faint surface fluorescence remained after a-treatment.
When endocytosed receptor-GFP fusions reach the vacuole , the receptor is
degraded while the GFP portion resists degradation and accumulates in the vacuole (Li et
aI. , 1999). Free GFP accumulation is , therefore, considered to indicate delivery of
receptor-GFP to the vacuole. Even in the absence of a-factor, the cells expressing
';k Ste2-8(297-360)-GFP fusion had vacuolar fluorescence that was similar to the cells
expressing wild-type receptors (Fig. 2 , top and middle rows , left panels). This result
suggests that the Ste2-8(297-360)-GFP fusion is able to undergo constitutive endocytosis
as well as ligand-induced endocytosis. On the other hand, the cells expressing the
endocytosis-defective Ste2-8(297-391)-GFP had no detectable free GFP in the vacuole in
the presence or in the absence of a-factor. Therefore, Ste2-8(297-391)-GFP is
apparently defective for constitutive endocytosis in addition to its a-factor-mediated
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endocytosis defect. Consistent with these results , western blotting analysis indicated very
little free GFP from cells expressing the Ste2-8(297-391)-GFP (Fig. 3 lane 2). The
Ste2-8(297-360)-GFP and the wild-type cells both produced larger amounts of free GFP
(Fig. 3 lanes 3 and 4 respectively). The relative proportion of GFP that accumulates in
the vacuole apparently depends on the growth rates of the cells , since cells that contained
fewer auxotrophies showed lesser vacuolar signal (Fig. 4A).
Overall, these results suggest that 71 amno acids at the C-termnal end of the
Ste2 cytoplasmic tail from residues 360 to 431 contain enough information to mediate
both the constitutive and a-factor-mediated endocytosis of the receptor and define a new
region in the tail that is critical for this process. In addition, more severe deletions
including the residues 360 to 391 in the Ste2-8(297-391)-GFP mutant completely disrupt
endocytosis. In other words , residues 391 to 431 are not sufficient to mediate
endocytosis alone.
Additional deletion analysis of Ste2-8(297-360)-GFP
In order to determne whether residues 360-391 car sufficient information to
confer endocytosis , I evaluated a constrct that fused these 31 amino acids to a severely
truncated receptor generating Ste2-8(297-360)-T391-GFP. The fluorescence analysis of
the resulting mutant indicated that the mutant receptors were incapable of mediating
factor-mediated endocytosis, and receptors accumulated at the cell surface with no
vacuglar GFP accumulation (Fig 4C). Therefore, the region between residues 360 to 431
requires sequences at both ends to function properly in endocytosis, since neither half of
this region is sufficient to car out endocytosis alone.
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Figure 2. Ligand-induced internalization of GFP-tagged a-factor receptors harboring
internal deletions in the C-termnal tail. Exponentially-growing cultures grown in rich
YM1 medium were treated with cycloheximide and then cultured for 15 min in the
absence or presence of 10- M a-factor. Further receptor endocytosis was inhibited 
incubating the cells with metabolic poisons NaN and KF. Cells were visualized by
fluorescence and Nomarski microscopic methods. First two columns show the control
cultures receiving no a-factor; the last two columns are a-factor-treated cells. GFP
fluorescence and Nomarski images are indicated below each column. Top row, cells
expressing Ste2-GFP (strain DJ1494). Middle row, cells expressing
Ste2-L,(297-360)-GFP (strain DJ1442). Bottom row, cells expressing
Ste2-8(297-391)-GFP (strain DJ1443).
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Figure 3. Western blotting analysis of the a-factor receptors harboring internal
deletions in the C-termnal tail. Lysates were prepared from cells expressing
Ste2-8(297-391)-GFP (lane 2), Ste2-8(297-360)-GFP (lane 3), Ste2-GFP (lane 4). Lane
1 is a negative control from cells expressing no GFP or Ste2. The samples were then
processed for SDS-PAGE analysis and resolved on a 10% SDS gel. Proteins were
detected with monoclonal anti-GFP antibodies and western blotting methods. Molecular
weight standards are indicated at the left. The positions of the GFP fusion proteins and
free GFP are indicated with arows on the right. The asterisk marks a
coIIonly-detected degradation product of Ste2-GFP (Li et aI., 1999). Strains were
DJ213- 3 (ste28), DJ1443 (Ste2-8(297-391)-GFP), DJ1442 (Ste2-8(297-360)-GFP) and
DJ1494 (Ste2-GFP).
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Figure 4. Ligand-induced internalization of GFP-tagged a-factor-receptors with internal
deletions combined with lysine substitutions and trncations in the C-termnal tail.
Exponentially-growing cultures in rich YM1 medium were treated with cycloheximide
and a-factor as described in Fig. 2. The first two columns are controls lacking a-factor;
the last two columns are a-factor-treated cells. GFP fluorescence images and Nomarski
images are indicated below each column. The GFP images shown in panels A and B were
derived from the same experiment, but divided into two panels for presentation purposes.
(A) Top row, cells expressing Ste2-GFP (strain DJ1460). Middle row, cells expressing
Ste2-8(297-360)-GFP (strain DJ1461). Bottom row, cells expressing
Ste2-Li(297-391)-GFP (strain DJ1462). (B) Top row , cells expressing
Ste2-8(297-360)-K374R-GFP (strain DJ1466). Middle row , cells expressing
Ste2-8(297-360)-K387R-GFP (strain DJ1467). Bottom row , cells expressing
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8(297-360)-K374R/K387R-GFP (strain DJ1468). (C) Top row, cells expressing
Ste2-GFP (strain DJ1460). Middle row
, cells expressing Ste2-8(297-360)-T391-GFP
(strain DJ1483). Bottom row
, cells expressing Ste2-8(297-360)- T399-GFP (strain
DJ1484).
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A five amno acid stretch on the tail has been postulated to be one of the weaker
endocytosis signals, since this sequence , GPFAD , resembles another endocytosis motif
NPFXD which is found on Ste3 and Kex2 (Tan et aI., 1996). Another receptor mutant
Ste2-8(297-360)-T399-GFP containing GPFAD in addition to the 360-391 sequence was
created to address this possibility. However, this sequence in conjunction with the 360-
391 sequence did not confer endocytosis to the receptor (Fig 4C). Therefore, the
structural determnants constituting the C-termnal end of the endocytosis signal extend
beyond residue 399. These elements may be required for direct recognition or for
folding.
Substituting the lysines in the region between residues 360-391
Lysine 337 in the SINDAKSS sequence has been shown to be required for
internalization of Ste2-T345 (Hicke and Riezman , 1996; Rohrer et aI. , 1993).
Furthermore, addition of the SINNDAKSS sequence to a severely truncated receptor
restored endocytosis but not if the lysine is changed to an arginine (Rohrer et aI., 1993).
As mentioned previously, a receptor mutant that contains no lysines in the tail is able to
undergo endocytosis , albeit six times more slowly (Terrell et aI. , 1998). There are two
lysines in the 360-391 region of the tail at positions 374 and 387. It has been previously
reported that Lys374 is the second most ubiquitinated lysine in the tail after the Lys337
of the SINNDAKSS sequence (Terrell et aI., 1998). I wished to test whether Lys374 or
Lys387 playa role in the activity of the endocytosis elements located in the C-termnal
elenii;mt. These two lysines were changed to arginines in the context of the
Ste2-8(297-360)-GFP mutant (see Fig. 1), and the abilty of these mutants to undergo
endocytosis was evaluated. Cells caring the mutant alleles were treated with
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cycloheximide and a-factor as described above. Fluorescence microscopy analysis
indicated that all of the lysine-to-arginine mutants were endocytosed upon a-factor
exposure (Fig. 4B). Punctate fluorescent structures appear after a-factor treatment
presumably corresponding to endosomes. Therefore , the endocytic defect observed with
Ste2-8(297-391)-GFP is not merely due to the absence of the two lysines in the 360-391
region.
Half-life assays and down regulation analyses of the deletion constructs
In order to obtain a quantitative evaluation of the effect of deletion and
lysine-to-arginine mutants on constitutive endocytosis , I assayed the half-life of
cell-surface receptor sites and total receptor protein. Briefly, the first assay utilizes
radioactive a-factor binding to whole cells and therefore measures receptor exit from the
plasma membrane. The second assay employs western blotting to determne the half-life
of total receptor protein turnover, since endocytosed receptors are degraded in the
vacuole. Thus the second assay measures receptor delivery to the vacuole.
Down regulation of receptor sites in the varous mutants are depicted in Fig. 5.
Cultures were treated with cycloheximide and cold a-factor as previously described
(Jenness and Spatrick, 1986). Cells were collected on filters , and further receptor
endocytosis was prevented by metabolic poisons. The bound cold a-factor was allowed
to dissociate. The binding of radioactivity was used as a measure of the remaining
receI?!or sites on the cell surface. Table 1 lists half-lives for receptor exit from the plasma
membrane derived from the graphs in Fig. 5. Consistent with previous findings, the
half-life for plasma membrane exit for the wild-type receptors was 7 minutes (Jenness
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and Spatrck, 1986). The Ste2-8(297-360)-GFP mutant and all of the lysine-to-arginine
mutants exited the plasma membrane more slowly than the wild-type receptors both in
the presence and in the absence of a-factor. These results are in agreement with my
previous observations with the fluorescence microscopy analysis (see Fig. 2, Fig. 4A and
4B). As expected, the Ste2-8(297-391)-GFP mutant had the most severe defect in both
constitutive and ligand-mediated endocytosis. In fact, constitutive endocytosis was
virtually abolished in the Ste2-8(297-391)-GFP mutant. Some residual loss of receptor
sites was detected for this mutant receptor in the presence of a-factor.
To measure receptor delivery to the vacuole in the absence of a-factor, the
half-life of total receptor protein was measured. Cultures were treated with
cycloheximide, and aliquots were removed at varous time points. The total receptor
protein remaining at each time point was detected by using western blotting methods with
anti-GFP antibody. The receptor bands were quantitated and plotted in Fig. 6. As
expected, Ste2-8(297-360)-GFP underwent constitutive endocytosis more slowly than the
wild-type control (Fig. 6A). The Ste2-8(297-391)-GFP mutant protein had the most
severe defect in constitutive endocytosis. Of the two lysine-to-arginine mutant receptors
Ste2-8(297-360)-K387R-GFP and double mutant Ste2-8(297-360)-K374R/K387R-GFP
were degraded at a rate that was similar to the Ste2-8(297-360)-GFP mutant (Fig. 6B).
The turnover of Ste2-8(297-360)-K374R-GFP was apparently slower than the other two
lysine-to-arginine mutants in this assay. However, radioactive a-factor binding assays
indicated that Ste2-8(297-360)-K374R-GFP exits the plasma membrane faster than the
other:two lysine-to-arginine mutant receptors in the absence of a-factor (see Fig. 5 and
Table 1). As mentioned above, protein turnover assay measures the remaining levels of
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Figure 5. Down regulation of GFP-tagged a-factor-receptors harboring internal
deletions and lysine substitutions in the C-termnal tail. Cultures received TAME and
cycloheximide and were untreated (0) or treated (8) with unlabeled a-factor as
described in Fig. 2. Aliquots of cells were removed at varous time points. The bound
unlabeled a-factor was allowed to dissociate. Cells were then incubated with 1abeled
factor, and the amount of radioactivity associated with the cells was measured.
Cultures were (A) Ste2-GFP (strain DJ1460) (B) Ste2-8(297-360)-GFP (DJ1461)
(C) Ste2-8(297-391)-GFP (DJ1462) (D) Ste2-8(297-360)-K374R-GFP (DJ1466)
(E) Ste2-8(297-360)-K387R-GFP (DJ1467) (F) Ste2-8(297-360)-K374R/K387R-GFP
(DJ1468).
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TABLE 1. The rates of plasma membrane exit for different Ste2 deletion constructs
Half-life for down regulation of receptors (min) 
Ste2 allele expressed (-) a-factor (+) a-factor
::-=
Ste2-GFP
Ste2-8(297 -360)-GFP
Ste2-8(297-391)-GFP stable
Ste2-8(297 -360)- K37 4R-GFP
Ste2-8(297 -360)- K387R-GFP ::90
Ste2-8(297 -360)- K37 4R/K387R-GFP ::90
3 The strains used were the same ones as in Fig. 5.
b The half-life values for plasma membrane exit of each receptor was derived from the
corresponding graph in Fig. 5.
No loss of receptor sites was detected for the 90 min duration of the assay.
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Figure 6, Turnover of GFP-tagged a-factor-receptors harboring internal deletions and
lysine mutations in the C-termnal tail. Cultures were treated with cycloheximide and
aliquotes were removed at varous time points and placed on ice with metabolic poisons
NaN3 and KF to prevent further receptor endocytosis. The samples were analyzed by
SDS-PAGE and western blotting methods. A. Samples were Ste2-GFP (closed
triangles), Ste2-8(297-360)-GFP (closed squares), Ste2-8(297-391)-GFP (open circles),
B. Ste2-8(297-360)-GFP (no plot symbol), Ste2-8(297-360)-K374R-GFP (open
circles), Ste2-8(297-360)-K387R-GFP (closed squares) and
Ste2- (297-360)-K374R/K387R-GFP (closed triangles).
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receptors in the cell and therefore provides a measure of the combined efficiency of
receptor down regulation, transport to the vacuole and degradation in the vacuole.
Therefore, taken at face value these results indicate that Ste2-8(297-360)-K374R-GFP
exits the plasma membrane faster than the other two lysine-to-arginine mutants , but it is
delivered to the vacuole at a slower rate.
As a second measure for delivery of the mutant receptors to vacuole, I took advantage of
appearance of free GFP that results from delivery of receptor-GFP to the vacuole. The
free GPP can be detected by western blotting analysis. I quantified the free GFP to the
receptor-fusion protein bands from western blots of untreated and a-factor-treated
mutants in Fig 7 A. The ratios of the receptor-fusion protein to the free GFP are listed in
Table 2 for each of the mutants. As expected, free GFP accumulation in strains
expressing Ste2-GFP and Ste2-8(297-360)-GFP was higher than the amount of free GFP
in strains expressing Ste2-8(297-391)-GFP. This result is in agreement with the western
blotting experiment performed in a different strain (see Fig. 3). The ratio of free GFP to
receptor-fusion protein was lower in the strain expressing Ste2-8(297-360)-K374R-GFP
than the other two lysine-to-arginine mutants. This finding is in agreement with the
results obtained from the receptor turnover assay (Fig. 6) and may reflect a defect in the
traffcking of this mutant to the vacuole. Interestingly, Lys374 is known to be
ubiquitinated in wild-type receptors, and thus ubiquitination of Lys374 may playa role
in intracellular trafficking events. However, because of the technical limitations in the
ability to measure these events accurately, it is not possible to make a definitive
conclusion at this time.
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Phosphorylation of the a-factor receptor
Receptors contain phosphorylated serine and threonine residues in the absence of
factor and then become hyperphosphorylated upon a-factor exposure (Reneke et aI.
1988). a-Factor-treatment causes a slight decrease in the mobility of Ste2 on SDS gels
(Hicke et aI., 1998) (Fig. 7 , compare lanes 1 and 7 in each panel). A similar mobilty
shift in wild-type receptors is thought to reflect phosphorylation because treatment with
phosphatases reverses the ligand-induced shift (Hicke et al. , 1998). The western blotting
analysis of the untreated and a-factor-treated mutants indicated that the
Ste2-8(297-391)-GFP mutant did not undergo the a-factor-induced mobility shift
whereas wild-type receptors and all other mutants did (Fig. 7). A previous study (Chen
and Konopka, 1996) utilized 2D gel analysis of tryptic fragments obtained from this
mutant and indicated that the Ste2-8(297-391) receptor maintains basal levels of
phosphorylation. They found that a-factor causes only a slight increase in the
phosphorylation status of this receptor (Chen and Konopka, 1996). I have not detected
any increase in the levels of phosphorylation. This discrepancy may be due to the
difference in sensitivity of the two assays. Since phosphorylation is required for
ubiquitination and the subsequent constitutive and ligand-mediated internalization of the
receptor, the internalization defect of Ste2-8(297-391)-GFP may result from the lack of
sufficient levels of phosphorylation or the lack of phosphorylation of specific residues.
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Figure 7. Western blotting analysis of GFP-tagged a-factor-receptors harboring internal
deletions and lysine mutations in the C-terminal tail. Lysates were prepared from cells
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untreated or treated with a-factor as described in Fig. 2. The samples were analyzed by
SDS-PAGE and western blotting methods with either (A) monoclonal or (B) poly clonal
anti-GFP antibodies. Lanes 1-6 show lysates from untreated cells and lanes 7- 12 show
cells treated with a-factor for 15 min. Lane 13 shows the untreated negative control cells
that do not express GFP or Ste2. The asterisks mark the position of the nonspecific bands
that are present in the control lane. Samples were Ste2-GFP (lanes 1 and 7),
Ste2-8(297-360)-GFP (lanes 2 and 8), Ste2-8(297-391)-GFP (lanes 3 and 9),
Ste2-8(297-360)-K374R-GFP (lanes 4 and 10) Ste2-8(297-360)-K387R-GFP (lanes 5
and 11) and Ste2-8(297-360)-K374R/K387R-GFP (lanes 6 and 12). Strains were
Ste2-GFP (strain DJ1460), Ste2-8(297-360)-GFP (DJ1461), Ste2-8(297-391)-GFP
(DJ1462), Ste2-8(297-360)-K374R-GFP (DJ1466), Ste2-8(297-360)-K387R-GFP
(DJ1467) and Ste2-8(297-360)-K374R/K387R-GFP (DJ1468).
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TABLE 2. The ratio of free GFP to the receptor-fusion protein for varous Ste2 mutants
- --- ' ' ; : ,
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Ste2 allele expressed Ratio of free GFP to full-length receptor-fusion
Ste2-GFP 1.00
Ste2-8(297 -360)-GFP 1.28
Ste2-8(297-391)-GFP
Ste2-8(297 -360)- K37 4R-GFP 0.37
Ste2-8(297 -360)- K387R-GFP 1.52
Ste2-8(297 -360)- K37 4R/K387R -GFP
li"
a The strains used were the same ones as in Fig. 7.
b The ratios of receptor-fusion protein were quantified from the immunoblot in Fig. 7 
The values were then normalized to the value obtained from the wild-type receptor.
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Discussion
In this chapter, I have utilized a deletion strategy to delineate an endocytic signal
in the cytoplasmic tail of the a-factor receptor. GFP fusions of internal deletions in the
Ste2 tail that lack the well-characterized endocytosis motif SINNDAKSS were studied.
The analysis revealed that the last 71 amno acids in the tail are able to mediate both
constitutive and a-factor-mediated internalization of the receptor. Structural features of
this region that were investigated further were the highly ubiquitinated Lys374, the
neighboring Lys387 and the GPFAD motif (residues 391-395). Lys374 and Lys387 were
unnecessar for the element to promote exit from the plasma membrane; however
Lys374 may play some role in intracellular trafficking. The GPFAD motif was not
sufficient to promote endocytosis, since the residues 360-399 provided no detectable
endocytic activity. Further analysis suggested that Ste2-8(297-391)-GFP was unable to
undergo hyperphosphorylation after a-factor treatment.
It has been proposed that the efficiency of endocytosis by the ubiquitination
pathway is a function of the number of the ubiquitinated lysine residues present in a
receptor mutant (Terrell et aI., 1998). Substituting all the lysines by arginines in the
context of the full-length receptor causes a six-fold reduction in the rate of plasma
membrane depletion of these receptors compared to the wild-type (Terrell et aI. , 1998).
There are a total of eight lysine residues in the Ste2 tail. Four of these lysines remain in
the Ste2-8(297-360)-GFP. The Ste2-8(297-360)-GFP mutant was endocytosed roughly
four fold slower than the wild-type receptors in the presence of the a-factor. In addition
loss of Lys387 or both Lys374 and Lys387 caused a further reduction in the rate of
receptor removalfrom the plasma membrane compared to the Ste2-8(297-360)-GFP
, '
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mutant that contained no lysine substitutions. These results are, therefore, in agreement
with the aforementioned view that the number of ubiquitinated lysines may affect the
efficiency of endocytosis. Multiple ubiquitinated lysines may provide more attachment
points for the endocytic machinery that recognizes these signals. Oligomerization of the
receptors may further enhance the efficiency of the process (Hicke, 2001; Yesilaltay and
Jenness, 2000).
Since lysine substitutions do not completely abolish the internalization of the
receptors, it has been speculated that lysines in the cytoplasmic loops may be
ubiquitinated in a level that is undetected but may be sufficient to car out the low level
of endocytosis that is observed for the mutant that lacks lysines (Terrell et aI., 1998).
This seems unlikely because a trncated receptor that has all of its cytoplasmic loops
intact and that signals and binds the ligand with wild-type affinity is unable to become
endocytosed. On the other hand, it is possible that these mutant receptors are
endocytosed through the action of an alternative mechanism. The NPFXD motif is one
of the lysine-free endocytosis signals in yeast. Additionally, PEST-like sequences were
indicated to playa role in the endocytosis of the a-factor receptor and uracil permease
(Marchal et aI. , 1998; Roth et aI., 1998).
Phosphorylation precedes ubiquitination (Hicke et aI., 1998). Phosphorylation of
the three serines of the SINAKSS sequence was shown to be required for the
ubiquitination and subsequent internalization of a trncated receptor (Hicke and
Riezman, 1996; Hicke et aI., 1998). In addition , strains which were deleted for the yeast
homologues of casein kinase I had defects in internalizing a-factor- and a-factor
receptors (Hicke et aI., 1998; Panek et aI., 1997). The lack of extensive phosphorylation
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in Ste2-8(297-391)-GFP could result from the absence of the critical serine and threonine
residues that are potentially required for ubiquitination of lysines in the rest of the tail.
Alternatively, but not mutually exclusive , the absence of the region 360-391 might cause
a conformational change that inhibits the exposure of the serines and threonines in the
rest of the tail to protein kinases. Therefore, the 360-391 region may either affect the
folding of the receptor tail so some other signal on the tail such as GPF AD is no longer
recognized by the endocytic machinery, or may directly be involved in recognition by the
endocytic machinery. Chen and Konopka (Chen and Konopka, 1996) showed that
Ste2-8(297-391)-GFP is phosphorylated in the absence of the pheromone. Addition 
pheromone caused a slight increase in the levels of phosphorylation (Chen and Konopka
1996). Mutating the four serine and threonine residues to alanines in the remainder of the
tail of Ste2-8(297-391)-GFP completely abolishes the basal levels of phosphorylation, as
detected in a phosphate labeling assay, and results in enhanced signaling activity (Chen
and Konopka, 1996). Even though constitutive phosphorylation of these residues,
observed in Ste2-8(297-391)-GFP, was apparently insufficient to confer endocytosis to
the receptor, I can not exclude the possibility that these residues playa role in the full-
length receptor.
Overall , these results define a new region in the cytoplasmic tail of the a-factor
receptor that mediates both the constitutive and ligand-mediated endocytosis of the
receptor.
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CHAPTER VI
DISCUSSION
...-
The work presented in this thesis aims to extend the current understanding of the
regulation of GPCR activity by analyzing the proteins that interact with the a-factor
pheromone receptor Ste2 , a GPCR from Saccharomyces cerevisiae. In addition, the role
of the cytoplasmic C-termnal domain of Ste2 in receptor interactions and in endocytosis
has been investigated.
Previous findings have implicated oligomerization of several mamalian GPCRs.
In this study, I present evidence indicating that the a-factor receptors from S. cerevisiae
also form oligomeric complexes in the plasma membrane (Chapter III). When
membranes containing two differentially-tagged receptors were solubilized with the
non-denaturing detergent n-dodecyl ~-D-maltoside and subjected to
immunoprecipitation, both tagged species were precipitated with antibodies specific for
either of the two tags. The formation of receptor oligomers was unaffected by ligand.
When two receptor mutants, one defective for ligand binding and one defective for
internalization, were individually coexpressed with wild-type receptors, and analyzed by
membrane fractionation and fluorescence microscopy, each mutant became competent for
endocytosis indicating that oligomeric receptor complexes were subject to endocytosis
and that unoccupied receptors could paricipate in these complexes. Due to the extensive
cointernalization of these complexes, it is plausible to argue that all of the receptors are
found in oligomers in the plasma membrane.
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The G~ and Gy subunits of the heterotrimeric G protein in yeast, Ste4 and Ste18
were also found to associate with the a-factor receptor upon immunoprecipitation of the
crosslinked complexes containing the receptor (Chapter IV). The points of contact
between receptor and G protein are not known, but most likely involve the residues
located at the third cytoplasmic loop of the receptor. Mutations in this region impair
receptor signaling. The C-termnal tail of Ste2 is not required for the receptor G protein
interactions as evidenced by the coprecipitation of Ste4 with a truncated mutant of Ste2
that lacks most of the tail. However, genetic evidence suggests that the C-termnal tail
may playa role in stabilizing the association between the receptor and the G protein. The
termnal tail may, therefore, be involved in formng additional contacts with the G~
subunit. These contacts may become critical when other contact points fail to associate.
The receptor-G protein interactions were detected both in the absence and in the
presence of the ligand. Since the extent of receptor oligomerization is unaffected by
ligand, it is unlikely that the receptor-G protein interaction is mediated by a change in the
oligomerization state of the receptor. However, these data do not exclude the possibilty
that a single heterotrimeric G protein associates with multiple receptors present in a
complex and that this interactions between the receptors and the G proteins require
receptor oligomerization.
Alternatively, heterotrimeric G proteins may also be present in multimeric
complexes that may interact with individual or multiple receptors. Such oligomerized G
protein arays have been observed during the analysis of the high resolution crystal
structure of Goi. Unfortnately, the methods used previously to study the interactions
between the GPCRs and G proteins, such as mutational studies or peptide binding
II . 
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experiments , do not address the possibility for requirement of receptor oligomers in these
interactions. The crystal structure of a GPCR bound to its cognate G protein would
answer such questions and identify the exact points of contact between these proteins.
. However, crystallization of protein complexes including components with vastly different
properties like a multiple transmembrane receptor and soluble G protein subunits may not
be possible. On the other hand, a mutational analysis approach could be undertaken to
obtain an oligomerization-defective GPCR to study the role of oligomerization on
receptor function including the receptor G protein interactions.
Yeast provides an amenable model for genetic manipulations. However, since the
role of oligomerization on receptor function is unkown, the oligomerization mutants
cannot be selected for phenotypes resulting from altered receptor functions. A visual
screen can help to identify the oligomerization-defective mutants of Ste2 (Mike Chang
and Duane Jenness, unpublished observations). The screen makes use of the observation
that an internalization-defective Ste2 mutant, Ste2- T326 , becomes competent for
endocytosis when coexpressed with wild-type receptors (Chapter III Table 2 and Figure
9). The interaction between Ste2- T326 and wild-type receptors has been confirmed by
coimmunoprecipitation experiments, indicating that the cointernalization is the result of
direct physical association (Chapter III Figure 10). To this end, random mutagenesis of
the Ste2- T326 gene can be performed and the mutagenized receptors can be expressed as
GFP fusion proteins with wild-type receptors. Fluorescence microscopy analysis of the
cells harboring mutagenized receptors would help to identify receptor mutants that cannot
oligomerize with the coexpressed wild-type receptors since they would remain on the
plasma membrane following treatment of cells with a-factor. On the other hand, the
oligomerization-proficient receptors would cointernalize with the wild-type receptors.
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Once such mutations are isolated, they can be tested in the context of the full-length
receptor for formation of oligomeric complexes in coimmunoprecipitation experiments.
This approach may help to identify the receptor segments involved in oligomerization
and to investigate the biological significance of receptor oligomers.
Oligomerization may also affect receptor functions by protein-protein
interactions , that is, the oligomerization parners may induce conformational changes in
each other. For example, when a-factor-binding defective receptors were coexpressed
with wild-type receptors , and treated by a-factor, the activated wild-type receptors may
induce an active receptor conformation on the oligomerized parner. This possibilty can
be addressed by coexpressing two receptor mutants , with one defective in ligand binding
(such as Ste2-T326) and the other defective in endocytosis (such as Ste2-S184R), and by
evaluating whether either receptor species is internalized upon treatment with a-factor.
Cointernalization would suggest that the activated Ste2- T326 could induce an active
conformation in the Ste2-S184R and therefore could cause Ste2-S184R and also the
oligomerized Ste2- T326 to be endocytosed.
The C-termnal cytoplasmic tail of the receptor includes redundant endocytic
signals. The well-characterized SINAKSS motif exclusively mediates the
endocytosis of a truncated form of Ste2, Ste2- T345 but it has little effect on endocytosis
in the context of the full-length receptor. SINDAKSS, however, is suffcient to confer
endocytosis to an endocytosis-defective tail-less receptor. A novel region in the Ste2 tail
that 1 sufficient to mediate endocytosis was discovered by deletion analyses (Chapter V).
This region extends from amino acid residues 360 to 431. Such redundant signals may be
required to 'provide avidity in interactions with the components of the endocytic
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machinery. Another way to achieve avidity is through oligomerization of receptors , and
thereby creating a high local concentration of endocytic signals. Thus, oligomerization
may have a broader role of facilitating all membrane trafficking events that involve the
receptors , including endocytosis and exit from the ER. Interestingly, when trncated
receptors were coexpressed with wild-type receptors , both forms of receptors affected the
intracellular buoyant membrane localization of each other, suggesting that oligomers may
be formng in the ER. For example, the membrane gradient analysis indicated that while
most of Ste2- T326-GFP is on the plasma membrane, about 18 % of receptors accumulate
in some intracellular comparments (Chapter Table 2). Fluorescence microscopy
images suggest that some of truncated receptors are not localized to the vacuoles and may
therefore be in the ER.When coexpressed with wild-type receptors, truncated receptors
were found to a lesser extent in these comparments , suggesting that the presence of the
wild-type receptors may have facilitated the exit of trncated receptor from the ER.
Similar effects of oligomerization in facilitating receptor exit from the ER have been
reported between GABA GBR1 and GBR2 receptors and between wild-type and
truncated forms of CCR5 (Kuner et aI., 1999; Benkrane et aI. , 1997).
More experiments are needed to assess at which comparment the oligomers form
inside the cell. To this end, pulse-chase experiments may be performed to analyze
oligomerization status of differentially-tagged receptors by coimmunoprecipitation. The
receptors may be tagged with GFP and HA, and therefore different species can be
resolved on SDS gels. To commt receptors to a specific cellular location , strains
producing temperature-sensitive mutant forms of proteins that mediate membrane
trafficking events from from ER to Golgi (sec12) or from Golgi to the plasma membrane
(sec1) can be used.
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Alternatively, Ste2-3, a temperature-sensitive mutant form of Ste2, may be useful
to assess the affect of receptor oligomerization on cellular localization. Ste2-3 is
transported directly to the vacuole without reaching the plasma membrane at
non-permissive temperature (Jenness et aI. , 1997). GFP-tagged Ste2-3 and HA-tagged
wild-type receptors can be coexpressed in cells and can be grown at non-permssive
temperature, and the effect of each receptor species on the localization of the other can be
assessed by fluorescence microscopy and membrane fractionation studies. The
localization of GFP-tagged Ste2-3 on the plasma membrane at non-permssive
temperature would indicate formation of receptor oligomers in the ER.
The possible role for receptor oligomerization in relationship to endocytosis and
signal transduction is unclear and controversial (Hebert et al. 1998). Interestingly, recent
evidence suggests a link between endocytosis and signaling in mammalian cells (Di Fiore
and De Camll, 2001). For example Trk receptors migrate from nerve termnals to the
cell body upon stimulation by nerve growth factor, and failure to endocytose Trk
receptors impede the ability of the nerve cell to induce a transcriptional response to the
hormone (Kuruvila et aI., 2000). Moreover, a scaffolding protein, arestin , interacts with
the phosphorylated cytoplasmic tails of activated GPCRs as well as with pars of
endocytic machinery, such as clathrn heavy chain and clathrn adaptor AP- , and
components of signaling machinery, such as c-Src and JNK3 , linkng endocytosis and
signal transduction (Hall et aI. , 1999). In yeast cells, for the a-factor receptor, these two
events seem independent since receptor mutants that are defective for endocytosis are
able to signal , and mutations in components of the signal transduction machinery are
competent for endocytosis: Even though signaling and endocytosis are separate events
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both events may require oligomerization. Oligomerization of receptors may provide
avidity and therefore facilitate interactions among components of both the signaling and
the endocytic machinery by causing a localized increase in the density of signals.
Another unanswered question is how many receptors are present in the oligomeric
complexes. The receptors form a complex that is approximately 8S in size in glycerol
gradient centrfugation. However, the relative contribution of the solubilzing detergent
to the size of the receptor complex is unkown. The molecular weight of the
detergent-solubilized complex can be determned from the Svedberg equation after
measuring the parial specific volume and the diffusion coefficient. The hydrodynamc
properties of another GPCR have been studied by a similar approach (Peterson et ai
1986). The association of the G proteins with the receptors is detected only in the
presence of a crosslinkng reagent, so the receptor oligomers may be the only protein
species in the solubilized complexes. In that case, the calculated molecular weight would
reflect the number of receptors in the complex.
In conclusion, the findings presented in this study indicate that the a-factor
pheromone receptors form oligomeric complexes and that these complexes are functional
units of endocytosis. The role of receptor oligomerization on receptor function remains
to be elucidated. In addition , biochemical evidence for a physical association between
factor receptors and heterotrimeric G proteins has been provided. Finally, a novel
region in the receptor tail that is sufficient to mediate endocytosis has been described.
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